View Filing Data

Print Document View Excel Document

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Jun. 30, 2018	Aug. 22, 2018	Dec. 31, 2017
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Trading Symbol	HAIN
Entity Registrant Name	HAIN CELESTIAL GROUP INC.
Entity Central Index Key	0000910406
Current Fiscal Year End Date	--06-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		103,952,111
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 3,887,102,679

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Current assets:
Cash and cash equivalents	$ 106,557	$ 137,055
Accounts receivable, less allowance for doubtful accounts of $1,828 and $404, respectively	252,708	225,765
Inventories	391,525	341,995
Prepaid expenses and other current assets	59,946	46,179
Current assets of discontinued operations	240,851	123,787
Total current assets	1,051,587	874,781
Property, plant and equipment, net	310,172	291,866
Goodwill	1,024,136	1,018,892
Trademarks and other intangible assets, net	510,387	521,228
Investments and joint ventures	20,725	18,998
Other assets	29,667	30,235
Noncurrent assets of discontinued operations	0	175,104
Total assets	2,946,674	2,931,104
Current liabilities:
Accounts payable	229,993	186,193
Accrued expenses and other current liabilities	116,001	106,727
Current portion of long-term debt	26,605	9,626
Current liabilities of discontinued operations	49,846	37,948
Total current liabilities	422,445	340,494
Long-term debt, less current portion	687,501	740,135
Deferred income taxes	86,909	98,346
Other noncurrent liabilities	12,770	15,975
Noncurrent liabilities of discontinued operations	0	23,322
Total liabilities	1,209,625	1,218,272
Commitments and contingencies (Note 17)
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	0	0
Common stock - $.01 par value, authorized 150,000 shares; issued: 108,422 and 107,989 shares, respectively; outstanding: 103,952 and 103,702 shares, respectively	1,084	1,080
Additional paid-in capital	1,148,196	1,137,724
Retained earnings	878,516	868,822
Accumulated other comprehensive loss	(184,240)	(195,479)
Total stockholders' equity including treasury stock	1,843,556	1,812,147
Less: Treasury stock, at cost, 4,470 and 4,287 shares, respectively	(106,507)	(99,315)
Total stockholders’ equity	1,737,049	1,712,832
Total liabilities and stockholders’ equity	$ 2,946,674	$ 2,931,104

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 1,828	$ 404
Preferred stock, par value (USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	108,422,000	107,989,000
Common stock, shares, outstanding	103,952,000	103,702,000
Treasury stock, shares	4,470,000	4,287,000

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Net sales	$ 2,457,769	$ 2,343,505	$ 2,392,864
Cost of sales	1,942,321	1,824,109	1,827,402
Gross profit	515,448	519,396	565,462
Selling, general and administrative expenses	339,431	312,583	288,023
Amortization of acquired intangibles	18,202	16,988	17,544
Acquisition related expenses, restructuring, integration and other charges	20,749	10,388	13,346
Accounting review and remediation costs, net of insurance proceeds	9,293	29,562	0
Goodwill impairment	7,700	0	84,548
Long-lived asset and intangibles impairment	14,033	40,452	43,200
Operating income	106,040	109,423	118,801
Interest and other financing expense, net	26,925	21,115	25,015
Other (income)/expense, net	(2,087)	430	16,469
Gain on fire insurance recovery	0	0	(9,752)
Income from continuing operations before income taxes and equity in net income of equity-method investees	81,202	87,878	87,069
(Benefit) provision for income taxes	(887)	22,466	59,451
Equity in net (income) loss of equity-method investees	(339)	(129)	47
Net income from continuing operations	82,428	65,541	27,571
Net (loss) income from discontinued operations, net of tax	(72,734)	1,889	19,858
Net income	$ 9,694	$ 67,430	$ 47,429
Net income (loss) per common share:
Basic net income per common share from continuing operations (USD per share)	$ 0.79	$ 0.63	$ 0.27
Basic net (loss) income per common share from discontinued operations (USD per share)	(0.70)	0.02	0.19
Basic net income per common share (USD per share)	0.09	0.65	0.46
Diluted net income per common share from continuing operations (USD per share)	0.79	0.63	0.26
Diluted net (loss) income per common share from discontinued operations (USD per share)	(0.70)	0.02	0.19
Diluted net income per common share (USD per share)	$ 0.09	$ 0.65	$ 0.46
Shares used in the calculation of net income (loss) per common share:
Basic (shares)	103,848	103,611	103,135
Diluted (shares)	104,477	104,248	104,183

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income	$ 9,694	$ 67,430	$ 47,429
Pre-tax amount
Foreign currency translation adjustments	11,497	(22,951)	(129,874)
Change in deferred gains (losses) on cash flow hedging instruments	(82)	(411)	(788)
Change in unrealized gain (loss) on available for sale investment	(190)	(53)	(129)
Total other comprehensive income (loss)	11,225	(23,415)	(130,791)
Tax (expense) benefit
Foreign currency translation adjustments	0	0	0
Change in deferred gains (losses) on cash flow hedging instruments	15	32	261
Change in unrealized gain (loss) on available for sale investment	(1)	15	50
Total other comprehensive income (loss)	14	47	311
After-tax amount
Foreign currency translation adjustments	11,497	(22,951)	(129,874)
Change in deferred gains (losses) on cash flow hedging instruments	(67)	(379)	(527)
Change in unrealized gain (loss) on available for sale investment	(191)	(38)	(79)
Total other comprehensive income (loss)	11,239	(23,368)	(130,480)
Total comprehensive income (loss)	$ 20,933	$ 44,062	$ (83,051)

Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Jun. 30, 2015	$ 1,727,667	$ 1,058	$ 1,072,427	$ 753,963	$ (58,150)	$ (41,631)
Beginning balance, shares at Jun. 30, 2015		105,841			3,229
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	47,429			47,429
Other comprehensive income (loss)	(130,480)					(130,480)
Issuance of common stock pursuant to compensation plans	4,400	$ 14	9,749		$ (5,363)
Issuance of common stock pursuant to compensation plans, shares		1,398			151
Issuance of common stock in connection with acquisition	16,308	$ 3	16,305
Issuance of common stock in connection with acquisition, shares		240
Stock-based compensation income tax effects	12,037		12,037
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(25,535)				$ (25,535)
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans, shares					638
Stock-based compensation expense	12,688		12,688
Ending balance at Jun. 30, 2016	1,664,514	$ 1,075	1,123,206	801,392	$ (89,048)	(172,111)
Ending balance, shares at Jun. 30, 2016		107,479			4,018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	67,430			67,430
Other comprehensive income (loss)	(23,368)					(23,368)
Issuance of common stock pursuant to compensation plans	1	$ 5	1,995		$ (1,999)
Issuance of common stock pursuant to compensation plans, shares		510			52
Stock-based compensation income tax effects	2,865		2,865
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(8,268)				$ (8,268)
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans, shares					217
Stock-based compensation expense	9,658		9,658
Ending balance at Jun. 30, 2017	$ 1,712,832	$ 1,080	1,137,724	868,822	$ (99,315)	(195,479)
Ending balance, shares at Jun. 30, 2017	107,989,000	107,989			4,287
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 9,694			9,694
Other comprehensive income (loss)	11,239					11,239
Issuance of common stock pursuant to compensation plans	0	$ 4	(4)		$ 0
Issuance of common stock pursuant to compensation plans, shares		433			0
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(7,192)				$ (7,192)
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans, shares					183
Stock-based compensation expense	10,476		10,476
Ending balance at Jun. 30, 2018	$ 1,737,049	$ 1,084	$ 1,148,196	$ 878,516	$ (106,507)	$ (184,240)
Ending balance, shares at Jun. 30, 2018	108,422,000	108,422			4,470

Consolidated Statement of Stockholders' Equity (Parenthetical) - $ / shares	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Statement of Stockholders' Equity [Abstract]
Common stock, par value (USD per share)	$ 0.01	$ 0.01	$ 0.01	$ 0.01

Consolidated Statements of Cash Flows $ in Thousands	12 Months Ended
Consolidated Statements of Cash Flows $ in Thousands	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)
Statement of Cash Flows [Abstract]
Net income	$ 9,694	$ 67,430	$ 47,429
Net (loss) income from discontinued operations, net of tax	(72,734)	1,889	19,858
Net income from continuing operations	82,428	65,541	27,571
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities from continuing operations:
Depreciation and amortization	60,809	59,568	58,689
Deferred income taxes	(21,503)	(10,456)	33,093
Equity in net (income) loss of equity-method investees	(339)	(129)	47
Stock-based compensation	11,177	9,658	12,688
Contingent consideration (income) expense	(2,281)	0	1,511
Gains on fire insurance recovery and other, net	0	0	(8,058)
Impairment charges	21,733	40,452	127,748
Bad debt expense	1,693	91	121
Other non-cash items, net	(153)	2,722	26,099
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
Accounts receivable	(24,841)	33,494	(12,078)
Inventories	(45,036)	209	(9,325)
Other current assets	(9,269)	33,109	(22,699)
Other assets and liabilities	(2,396)	(4,521)	3,763
Accounts payable and accrued expenses	49,286	2,957	(54,198)
Net cash provided by operating activities - continuing operations	121,308	232,695	184,972
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisitions of businesses, net of cash acquired	(12,368)	(19,544)	(157,061)
Purchases of property and equipment	(70,891)	(47,307)	(47,917)
Proceeds from sale of assets and other	738	6,419	0
Net cash used in investing activities - continuing operations	(82,521)	(60,432)	(204,978)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility	65,000	90,000	323,904
Repayments under bank revolving credit facility	(400,220)	(181,203)	(145,053)
Borrowings under term loan	299,245	0	0
Repayments under term loan	(3,750)	0	0
Repayments of senior notes	0	0	(150,000)
Repayments of other debt, net	(996)	(19,199)	(12,770)
(Funding) proceeds of discontinued operations entities	(21,568)	(25,921)	7,789
Acquisition related contingent consideration	0	(2,498)	(1,547)
Shares withheld for payment of employee payroll taxes	(7,193)	(8,268)	(25,535)
Net cash used in financing activities - continuing operations	(69,482)	(147,089)	(3,212)
Effect of exchange rate changes on cash	197	(3,114)	(11,295)
CASH FLOWS FROM DISCONTINUED OPERATIONS
Cash (used in) provided by operating activities	(14,086)	(12,772)	32,921
Cash used in investing activities	(10,752)	(15,813)	(29,367)
Cash provided by (used in) financing activities	21,361	25,591	(8,037)
Net cash used in discontinued operations	(3,477)	(2,994)	(4,483)
Net increase/(decrease) in cash and cash equivalents	(33,975)	19,066	(38,996)
Cash and cash equivalents at beginning of year	146,992	127,926	166,922
Cash and cash equivalents at end of year	113,017	146,992	127,926
Less: cash and cash equivalents of discontinued operations	(6,460)	(9,937)	(12,932)
Cash and cash equivalents of continuing operations at end of year	$ 106,557	$ 137,055	$ 114,994

Description of Business and Basis of Presentation	12 Months Ended
Description of Business and Basis of Presentation	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Description of Business The Hain Celestial Group, Inc., a Delaware corporation, and its subsidiaries (collectively, the “Company,” and herein referred to as “Hain Celestial,” “we,” “us,” and “our”) was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — To Create and Inspire A Healthier Way of Life^TMand be the leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide. The Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-for-you” products, providing consumers with the opportunity to lead A Healthier Way of Life™. Hain Celestial is a leader in many organic and natural products categories, with many recognized brands in the various market categories it serves, including Almond Dream^®, Arrowhead Mills^®, Bearitos^®, Better Bean^®, BluePrint^®, Casbah^®, Celestial Seasonings^®, Clarks™, Coconut Dream^®, Cully & Sully^®, Danival^®, DeBoles^®, Earth’s Best^®, Ella’s Kitchen^®, Empire^®, Europe’s Best^®, Farmhouse Fare^™, Frank Cooper’s^®, FreeBird^®, Gale’s^®, Garden of Eatin’^®, GG UniqueFiber^TM, Hain Pure Foods^®, Hartley’s^®, Health Valley^®, Imagine^®, Johnson’s Juice Co.^®, Joya^®, Kosher Valley^®, Lima^®, Linda McCartney’s^® (under license), MaraNatha^®, Mary Berry (under license), Natumi^®, New Covent Garden Soup Co.^®, Orchard House^®, Plainville Farms^®, Rice Dream^®, Robertson’s^®, Rudi’s Gluten-Free Bakery^®, Rudi’s Organic Bakery^®, Sensible Portions^®, Spectrum Organics^®, Soy Dream^®, Sun-Pat^®, Sunripe^®, SunSpire^®, Terra^®, The Greek Gods^®, Tilda^®, Walnut Acres^®, WestSoy^®, Yorkshire Provender^®, Yves Veggie Cuisine^®and William’s™. The Company’s personal care products are marketed under the Alba Botanica^®, Avalon Organics^®, Earth’s Best^®, JASON^®, Live Clean^® and Queen Helene^® brands. During fiscal year 2016, the Company commenced a strategic review, called “Project Terra,” that resulted in the Company redefining its core platforms, starting with the United States segment, for future growth based upon consumer trends to create and inspire A Healthier Way of Life™. In addition, beginning in fiscal year 2017, the Company launched Cultivate Ventures (“Cultivate”), a venture unit with a twofold purpose: (i) to strategically invest in the Company’s smaller brands in high potential categories such as BluePrint^® cold-pressed juices, SunSpire^® chocolates and DeBoles^® pasta by giving those products a dedicated, creative focus for refresh and relaunch; and (ii) to incubate small acquisitions until they reach the scale for the Company’s core platforms. See Note 19, Segment Information, for information on the Company’s operating and reportable segments and the effect the formation of Cultivate had thereon. Another key initiative from Project Terra was the identification of global cost savings, as well as removing complexities from the business. Under this plan, the Company aims to achieve $350 million in global savings by fiscal 2020, a portion of which the Company intends to reinvest into its brands. This review includes streamlining the Company’s manufacturing plants, co-packers and supply chain, eliminating served categories or brands within categories and product rationalization initiatives which are aimed at eliminating slow moving stock-keeping units (“SKUs”). During fiscal 2018, the Company initiated a SKU rationalization, which included the removal of over 400 SKUs for a total of over 1,100 SKUs to date identified as part of Project Terra. Additionally, the Company, with the assistance of outside consultants, engaged in an evaluation of its trade investment in the United States segment. Based on this assessment, the Company determined that its trade investment could be utilized more effectively, and therefore, beginning in fiscal 2017, the Company developed plans to shift from a model of investing in trade at the non-consumer facing level to more consumer facing activities. Discontinued Operations In March 2018, the Company’s Board of Directors approved a plan to sell all of the operations of the Hain Pure Protein Corporation (“HPPC”) and EK Holdings, Inc. (“Empire”) operating segments, which are reported in the aggregate as the Hain Pure Protein reportable segment. These dispositions are being undertaken to reduce complexity in the Company’s operations and simplify the Company’s brand portfolio, in addition to allowing additional flexibility to focus on opportunities for growth and innovation in the Company’s more profitable and faster growing core businesses. Collectively, these dispositions represent a strategic shift that will have a major impact on the Company’s operations and financial results and have been accounted for as discontinued operations. See Note 5, Discontinued Operations, for additional information. Changes in Segments Effective July 1, 2017, due to changes to the Company’s internal management and reporting structure, the United Kingdom operations of the Ella’s Kitchen^® brand (“Ella’s Kitchen UK”), which was previously included within the United States reportable segment, became a separate operating segment and was aggregated within the United Kingdom reportable segment. See Note 19, Segment Information, for additional information on the Company’s operating and reportable segments. Basis of Presentation The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net income includes the Company’s equity in the current earnings or losses of such companies. Unless otherwise indicated, references in these consolidated financial statements to 2018, 2017 and 2016 or “fiscal” 2018, 2017 and 2016 or other years refer to our fiscal year ended June 30 of that respective year and references to 2019 or “fiscal” 2019 refer to our fiscal year ending June 30, 2019. Reclassifications Certain prior year amounts have been reclassified to conform with current year presentation. Discontinued Operations The financial statements separately report discontinued operations and the results of continuing operations (See Note 5). All footnotes exclude discontinued operations unless otherwise noted. Use of Estimates The financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. These estimates include, among others, revenue recognition, trade promotions and sales incentives, valuation of accounts and chargeback receivables, accounting for acquisitions, valuation of long-lived assets, goodwill and intangible assets, stock-based compensation, and valuation allowances for deferred tax assets. We believe in the quality and reasonableness of our critical accounting estimates; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have consistently applied.

Summary of Significant Accounting Policies and Practices

12 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies and Practices

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND PRACTICES

Cash and Cash Equivalents

The Company considers cash and cash equivalents to include cash in banks, commercial paper and deposits with financial institutions that can be liquidated without prior notice or penalty. The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Revenue Recognition

Sales are recognized when the earnings process is complete, which occurs when the product is shipped in accordance with the terms of agreements, title and risk of loss transfers to the customer, collection is probable and pricing is fixed or determinable. Net sales include shipping and handling charges billed to the customer and are reported net of discounts, trade promotions and sales incentives, consumer coupon programs and other costs, including estimated allowances for returns, allowances and discounts associated with aged or potentially unsalable product, and prompt pay discounts.

During the fourth quarter of fiscal 2016, the Company identified the practice of granting additional concessions to certain distributors in the United States and commenced an internal accounting review in order to (i) determine whether the revenue associated with those concessions was accounted for in the correct period and (ii) evaluate its internal control over financial reporting. The Audit Committee of the Company’s Board of Directors separately conducted an independent review of these matters and retained independent counsel to assist in their review. On November 16, 2016, the Company announced that the independent review of the Audit Committee was completed and that the review found no evidence of intentional wrongdoing in connection with the preparation of the Company’s financial statements.

Management’s accounting review included consideration of certain side agreements and concessions provided to distributors in the United States in fiscal 2016, including payment terms beyond the customer’s standard terms, rights of return of product and post-sale concessions, most of which were associated with sales that occurred at the end of the quarter. It had been the Company’s policy to record revenue related to these distributors when title of the product transfers to the distributor. The Company concluded that its historical accounting policy for these distributors was appropriate as the sales price is fixed or determinable at the time ownership transfers to these distributors, based on the Company’s ability to make a reasonable estimate of future returns and certain concessions at the time of shipment.

Trade Promotions and Sales Incentives

Trade promotions and sales incentives include price discounts, slotting fees, in-store display incentives, cooperative advertising programs, new product introduction fees and coupons and are used to support sales of the Company’s products. These incentives are deducted from our net sales to determine reported net sales. The recognition of expense for these programs involves the use of judgment related to performance and redemption estimates. Differences between estimated expense and actual redemptions are normally insignificant and recognized as a change in estimate in the period such change occurs.

Trade Promotions. Accruals for trade promotions are recorded primarily at the time a product is sold to the customer based on expected levels of performance. Settlement of these liabilities typically occurs in subsequent periods primarily through an authorization process for deductions taken by a customer from amounts otherwise due to the Company.

Coupon Redemption. Coupon redemption costs are accrued in the period in which the coupons are offered, based on estimates of redemption rates that are developed by management. Management estimates are based on recommendations from independent coupon redemption clearing-houses as well as on historical information. Should actual redemption rates vary from amounts estimated, adjustments to accruals may be required.

Valuation of Accounts and Chargebacks Receivable and Concentration of Credit Risk

The Company routinely performs credit evaluations on existing and new customers. The Company applies reserves for delinquent or uncollectible trade receivables based on a specific identification methodology and also applies an additional reserve based on the experience the Company has with its trade receivables aging categories. Credit losses have been within the Company’s expectations in recent years. While one of the Company’s customers represented approximately 11% and 12% of trade receivables balances as of June 30, 2018 and 2017, the Company believes there is no significant or unusual credit exposure at this time.

Based on cash collection history and other statistical analysis, the Company estimates the amount of unauthorized deductions customers have taken that we expect will be collected and repaid in the near future and records a chargeback receivable. Differences between estimated collectible receivables and actual collections are recognized in earnings in the period such differences are determined.

Sales to one customer and its affiliates approximated 11%, 12% and 12% of net sales during the fiscal years ended June 30, 2018, 2017 and 2016, respectively. Sales to a second customer and its affiliates approximated 11%, 11% and 12% of net sales during the fiscal years ended June 30, 2018, 2017, and 2016, respectively.

In addition, cash and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand.

Inventory

Inventory is valued at the lower of cost or market, utilizing the first-in, first-out method. The Company provides write-downs for finished goods expected to become non-saleable due to age and specifically identifies and provides for slow moving or obsolete raw ingredients and packaging.

Property, Plant and Equipment

Property, plant and equipment is carried at cost and depreciated or amortized on a straight-line basis over the estimated useful lives or lease term (for leasehold improvements), whichever is shorter. The Company believes the useful lives assigned to our property, plant and equipment are within ranges generally used in consumer products manufacturing and distribution businesses. The Company’s manufacturing plants and distribution centers, and their related assets, are reviewed when impairment indicators are present by analyzing underlying cash flow projections. The Company believes no impairment of the carrying value of such assets exists other than as disclosed under Note 8, Property, Plant and Equipment, Net, and Note 5, Discontinued Operations. Ordinary repairs and maintenance costs are expensed as incurred. The Company utilizes the following ranges of asset lives:



Buildings and improvements		10 - 40 years
Machinery and equipment		3 - 20 years
Furniture and fixtures		3 - 15 years

Leasehold improvements are amortized over the shorter of the respective initial lease term or the estimated useful life of the assets, and generally range from 3 to 15 years.

Goodwill and Other Indefinite-Lived Intangible Assets

Goodwill and other intangible assets with indefinite useful lives are not amortized but rather are tested at least annually for impairment, or when circumstances indicate that the carrying amount of the asset may not be recoverable. The Company performs its annual test for impairment at the beginning of the fourth quarter of its fiscal year.

Goodwill is tested for impairment at the reporting unit level. A reporting unit is an operating segment or a component of an operating segment. Goodwill is tested for impairment by either performing a qualitative evaluation or a two-step quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for some or all reporting units and perform a two-step quantitative impairment test. The impairment test for goodwill requires the Company to compare the fair value of a reporting unit to its carrying value, including goodwill. The Company uses a blended analysis of a discounted cash flow model and a market valuation approach to determine the fair values of its reporting units. If the carrying value of a reporting unit exceeds its fair value, the Company would then compare the carrying value of the goodwill to its implied fair value in order to determine the amount of the impairment, if any.

Indefinite-lived intangible assets are tested for impairment by comparing the fair value of the asset to the carrying value. Fair value is determined based on a relief from royalty method that include significant management assumptions such as revenue growth rates, weighted average cost of capital, and assumed royalty rates. If the fair value is less than the carrying value, the asset is reduced to fair value.

See Note 9, Goodwill and Other Intangible Assets for information on goodwill and intangibles impairment charges.

Cost of Sales

Included in cost of sales are the cost of products sold, including the costs of raw materials and labor and overhead required to produce the products, warehousing, distribution, supply chain costs, as well as costs associated with shipping and handling of our inventory.

Foreign Currency Translation and Remeasurement

The assets and liabilities of international operations are translated at the exchange rates in effect at the balance sheet date. Revenue and expense accounts are translated at the monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s international operations are reported as a component of Accumulated other comprehensive income/(loss) in the Company’s consolidated balance sheets. Gains and losses arising from intercompany foreign currency transactions that are of a long-term nature are reported in the same manner as translation adjustments.

Gains and losses arising from intercompany foreign currency transactions that are not of a long-term nature and certain transactions of the Company’s subsidiaries which are denominated in currencies other than the subsidiaries’ functional currency are recognized as incurred in Other (income)/expense, net in the Consolidated Statements of Income.

Gain on Recovery of Insurance Proceeds

On October 25, 2014, a fire occurred at our Tilda rice milling facility in the United Kingdom. As a result, the Company recognized a gain of $9,752, representing the excess of the insurance proceeds over the net book value of fixed assets destroyed in the fire. The milling facility was fully functional at the end of the third quarter of fiscal 2016.

Selling, General and Administrative Expenses

Included in selling, general and administrative expenses are advertising costs, promotion costs not paid directly to the Company’s customers, salary and related benefit costs of the Company’s employees in the finance, human resources, information technology, legal, sales and marketing functions, facility related costs of the Company’s administrative functions, research and development costs, and costs paid to consultants and third party providers for related services.

Research and Development Costs

Research and development costs are expensed as incurred and are included in selling, general and administrative expenses in the accompanying consolidated financial statements. Research and development costs amounted to $9,696 in fiscal 2018, $10,130 in fiscal 2017 and $11,354 in fiscal 2016, consisting primarily of personnel related costs. The Company’s research and development expenditures do not include the expenditures on such activities undertaken by co-packers and suppliers who develop numerous products on behalf of the Company and on their own initiative with the expectation that the Company will accept their new product ideas and market them under the Company’s brands.

Advertising Costs

Advertising costs, which are included in selling, general and administrative expenses, amounted to $35,138 in fiscal 2018, $30,333 in fiscal 2017 and $24,835 in fiscal 2016. Such costs are expensed as incurred.

Income Taxes

The Company follows the liability method of accounting for income taxes. Under the liability method, deferred taxes are determined based on the differences between the financial statement and tax bases of assets and liabilities at enacted rates in effect in the years in which the differences are expected to reverse. Valuation allowances are provided for deferred tax assets to the extent it is more likely than not that the deferred tax assets will not be recoverable against future taxable income.

The Company recognizes liabilities for uncertain tax positions based on a two-step process prescribed by the authoritative guidance. The first step requires the Company to determine if the weight of available evidence indicates that the tax position has met the threshold for recognition; therefore, the Company must evaluate whether it is more likely than not that the position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step requires the Company to measure the tax benefit of the tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than 50% likely of being realized upon ultimate settlement. The Company reevaluates the uncertain tax positions each period based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Depending on the jurisdiction, such a change in recognition or measurement may result in the recognition of a tax benefit or an additional charge to the tax provision in the period. The Company records interest and penalties in the provision for income taxes.

Fair Value of Financial Instruments

The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. At June 30, 2018 and 2017, the Company had $99 and $21,800, respectively, invested in money market funds, which are classified as cash equivalents. At June 30, 2018 and 2017, the carrying values of financial instruments such as accounts receivable, accounts payable, accrued expenses and other current liabilities, as well as borrowings under our credit facility and other borrowings, approximated fair value based upon either the short-term maturities or market interest rates of these instruments.

Derivative Instruments

The Company utilizes derivative instruments, principally foreign exchange forward contracts, to manage certain exposures to changes in foreign exchange rates. The Company’s contracts are hedges for transactions with notional balances and periods consistent with the related exposures and do not constitute investments independent of these exposures. These contracts, which are designated and documented as cash flow hedges, qualify for hedge accounting treatment in accordance with ASC 815, Derivatives and Hedging. Exposure to counterparty credit risk is considered low because these agreements have been entered into with high quality financial institutions.

All derivative instruments are recognized on the balance sheet at fair value. The effective portion of changes in the fair value of derivative instruments that qualify for hedge accounting treatment are recognized in stockholders’ equity as a component of Accumulated other comprehensive income (loss) until the hedged item is recognized in earnings. Changes in the fair value of fair value hedges, derivatives that do not qualify for hedge accounting treatment, as well as the ineffective portion of any cash flow hedges, are recognized currently in earnings as a component of Other (income)/expense, net in the accompanying financial statements.

Stock-Based Compensation

The Company has employee and director stock-based compensation plans.

The fair value of stock-based compensation awards is recognized as an expense over the vesting period using the straight-line method. For awards that contain a market condition, expense is recognized over the derived service period using a Monte Carlo simulation model. For restricted stock awards which include performance criteria, compensation expense is recorded when the achievement of the performance criteria is probable and is recognized over the performance and vesting service periods. Compensation expense is recognized for only that portion of stock-based awards that are expected to vest. Therefore, estimated forfeiture rates that are derived from historical employee termination activity are applied to reduce the amount of compensation expense recognized. If the actual forfeitures differ from the estimate, additional adjustments to compensation expense may be required in future periods.

The Company receives an income tax deduction in certain tax jurisdictions for restricted stock grants when they vest and for stock options exercised by employees equal to the excess of the market value of our common stock on the date of exercise over the option price. Excess tax benefits (tax benefits resulting from tax deductions in excess of compensation cost recognized) are classified as a cash flow provided by operating activities in the accompanying Consolidated Statements of Cash Flows.

Valuation of Long-Lived Assets

The Company periodically evaluates the carrying value of long-lived assets, other than goodwill and intangible assets with indefinite lives, held and used in the business when events and circumstances occur indicating that the carrying amount of the asset may not be recoverable. An impairment test is performed when the estimated undiscounted cash flows associated with the asset or group of assets is less than their carrying value. Once such impairment test is performed, a loss is recognized based on the amount, if any, by which the carrying value exceeds the estimated fair value for assets to be held and used.

See Note 8, Property, Plant and Equipment, Net, and Note 5, Discontinued Operations, for information on long-lived asset impairment charges.

Net Income Per Share

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted net income per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock.

Newly Adopted Accounting Pronouncements

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. This ASU, among other things, changes the treatment of share-based payment transactions by recognizing the impact of excess tax benefits or deficiencies related to exercised or vested awards in income tax expense in the period of exercise or vesting, instead of additional paid in capital. The updated guidance is effective for fiscal years beginning after December 15, 2016 and interim periods within those annual periods. The Company adopted this new guidance effective July 1, 2017. As a result of this adoption:


•	As required, we prospectively recognized a tax benefit of $309 in the income tax line item of our consolidated income statement for the fiscal year ended June 30, 2018 related to excess tax benefits upon vesting or settlement in that period.


•	We elected to adopt the cash flow presentation of the excess tax benefits retrospectively. As a result, we decreased our cash used in financing activities by $3,298 and $11,317 for the fiscal years ended June 30, 2017 and 2016, respectively.


•	We have elected to continue to estimate the number of stock-based awards expected to vest, rather than electing to account for forfeitures as they occur to determine the amount of compensation costs to be recognized in each period.


•	We have not changed our policy on statutory withholding requirements and will continue to allow an employee to withhold at the minimum statutory withholding requirements. Amounts paid by us to taxing authorities when directly withholding shares associated with employees’ income tax withholding obligations are classified as a financing activity in our cash flow statement.


•	We excluded the excess tax benefits from the assumed proceeds available to repurchase shares in the computation of our diluted earnings per share for the fiscal year ended June 30, 2018.


•	We did not have any material excess tax benefits previously recognized in additional paid-in capital; therefore, it was not necessary to record a deferred tax asset for the unrecognized tax benefits with an adjustment to opening retained earnings.

Recently Issued Accounting Pronouncements Not Yet Effective

In June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. The guidance largely aligns the accounting for share-based payment awards issued to employees and nonemployees, whereby the existing employee guidance will apply to nonemployee share-based transactions (as long as the transaction is not effectively a form of financing), with the exception of specific guidance related to the attribution of compensation cost. The cost of nonemployee awards will continue to be recorded as if the grantor had paid cash for the goods or services. In addition, the contractual term will be able to be used in lieu of an expected term in the option-pricing model for nonemployee awards. The ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. The ASU is required to be applied on a prospective basis to all new awards granted after the date of adoption. In addition, any liability-classified awards that have not been settled and equity-classified awards for which a measurement date has not been established by the adoption date should be remeasured at fair value as of the adoption date with a cumulative effect adjustment to opening retained earnings in the year of adoption. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2018-07.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. The ASU expands and refines hedge accounting for both financial and non-financial risk components, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The effective date of the new standard for public companies is for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition with a cumulative effect adjustment recorded to opening retained earnings as of the initial adoption date. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2017-12.

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting, which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The guidance is effective for annual periods beginning after December 15, 2017, with early adoption permitted, including adoption in any interim period for which financial statements have not yet been issued. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2017-09.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairments tests in fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2017-04.

In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill and consolidation. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within those periods, with early adoption permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2017-01.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. Currently, U.S. GAAP prohibits recognizing current and deferred income tax consequences for an intra-entity asset transfer until the asset has been sold to an outside party. ASU 2016-16 states that an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The new standard is effective for public companies in fiscal years beginning after December 15, 2017. Early adoption is permitted. The amendments should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption.

The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-16.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (A Consensus of the Emerging Issues Task Force). ASU 2016-15 provides guidance on the classification of certain cash receipts and payments in the statement of cash flows. The guidance must be applied retrospectively to all periods presented but may be applied prospectively if retrospective application would be impracticable. The new standard is effective for public companies in fiscal years beginning after December 15, 2017. Early adoption is permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-15.

In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 revises accounting for operating leases by a lessee, among other changes, and requires a lessee to recognize a liability to make lease payments and an asset representing its right to use the underlying asset for the lease term in the balance sheet. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases, to clarify how to apply certain aspects of the new leases standard. The amendments address the rate implicit in the lease, impairment of the net investment in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments, among other issues. In addition, in July 2018, the FASB issued ASU 2018-11, Leases (Topic 842), Targeted Improvements, which provides an additional (and optional) transition method to adopt the new leases standard. Under the new transition method, a reporting entity would initially apply the new lease requirements at the effective date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, continue to report comparative periods presented in the financial statements in the period of adoption in accordance with current U.S. GAAP (i.e., ASC 840, Leases) and provide the required disclosures under ASC 840 for all periods presented under current U.S. GAAP. Further ASU 2018-11 contains a new practical expedient that allows lessors to avoid separating lease and associated non-lease components within a contract if certain criteria are met. The guidance in ASUs 2016-02, 2018-10 and 2018-11 is effective for the first interim and annual periods beginning after December 15, 2018, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. We are currently assessing the impact the new standard will have on our consolidated financial statements, which will consist primarily of a balance sheet gross up of our operating leases to show equal and offsetting lease assets and lease liabilities.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. ASU 2016-01 requires that most equity investments be measured at fair value, with subsequent changes in fair value recognized in net income. The pronouncement also impacts financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. ASU 2016-01 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those annual periods. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-01.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This guidance outlines a single, comprehensive model for accounting for revenue from contracts with customers, providing a single five-step model to be applied to all revenue transactions. The guidance also requires improved disclosures to assist users of the financial statements to better understand the nature, amount, timing and uncertainty of revenue that is recognized. Subsequent to the issuance of ASU 2014-09, the FASB issued various additional ASUs clarifying and amending this new revenue guidance. The guidance is effective for public entities for annual reporting periods beginning after December 15, 2017, including interim reporting periods within that period.

We evaluated the impact of the new standard on certain common practices currently employed by us and by other manufacturers of consumer products, such as scan-based trading, product rebates and other pricing allowances, product returns, trade promotions, sales broker commissions and slotting fees. Based on the results of our assessment, we determined that our current accounting practices for these activities is consistent with the requirements under the new revenue guidance and that there will not be any material changes to the nature, timing or amount of revenue recognition for these activities upon adoption. We adopted the new guidance on July 1, 2018 using the modified retrospective transition method. Based on the results of our assessment as described above, the adoption of ASU 2014-09 is not expected to materially impact our results of operations or financial position.

Chief Executive Officer Succession Plan	12 Months Ended
Chief Executive Officer Succession Plan	Jun. 30, 2018
Compensation Related Costs [Abstract]
Chief Executive Officer Succession Plan	CHIEF EXECUTIVE OFFICER SUCCESSION PLAN On June 25, 2018, Hain announced a Chief Executive Officer (“CEO”) succession plan, whereby the current CEO, Irwin D. Simon, will terminate employment with the Company upon the hiring of a new CEO. Following the hiring of a new CEO, Mr. Simon will become Non-Executive Chairman of the Board of Directors for a transition period. Under the terms of the Succession Agreement (the “Agreement”), Mr. Simon’s employment with the Company will terminate on the date immediately prior to the first date of employment of a new CEO of the Company to be appointed by the Company’s Board of Directors (the “Succession Date”). Prior to the Succession Date, Mr. Simon will continue his position as President and CEO and will assist the Board of Directors in the identification and hiring of a successor to his position during this period. Cash Separation Payments The Agreement provides for a cash separation payment of $34,294 payable in a single lump sum and cash benefits continuation costs of $209. These costs are being recognized over the term of the Company’s best estimate of the Succession Date, currently estimated to occur no later than December 31, 2018. Expense recognized in connection with these payments was $1,453 in the twelve months ended June 30, 2018. Long Term Incentive Award Mr. Simon was granted 164 total shareholder return (“TSR”) performance based awards on September 26, 2017. The performance period will end on June 30, 2019. Under the Agreement, he will be entitled to compensation if the TSR components are met. The Agreement modifies Mr. Simon’s award such that his award went from improbable of being earned to probable since the Agreement allows him to be eligible for the award while he is no longer an employee. Accordingly, the Company determined that a Type III modification pursuant to ASC 718 has occurred. Therefore, in accordance with ASC 718, the Company determined the fair value of the replacement award as of the modification date, utilizing the Monte Carlo valuation model. As a result, the fair value of the TSR performance based awards granted on September 26, 2017 was reduced from $31.60 per share to $3.19 per share based on the lower likelihood of attainment, resulting in revised expense of $524, which will be amortized on a straight-line basis from June 24, 2018 through the estimated Succession Date. In the fiscal year ended June 30, 2018, the Company reversed the previously recognized stock-based compensation expense of $2,244 and recognized $22 of stock-based compensation expense associated with the modified grant, resulting in a net reduction to stock-based compensation expense of $2,222 in the twelve months ended June 30, 2018 associated with the modification of this grant. Accelerated Stock Compensation The Agreement allows for acceleration of vesting of all service-based awards outstanding at the Succession Date. In connection with these accelerations, the Company expects to recognize additional stock-based compensation expense of $445 ratably through the Succession Date, of which $19 was recognized in the twelve months ended June 30, 2018.

Earnings Per Share

12 Months Ended

Jun. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:



	Fiscal Year Ended June 30,
	2018			2017		2016
Numerator:
Net income from continuing operations	$	82,428		$	65,541	$	27,571
Net (loss) income from discontinued operations, net of tax	$	(72,734	)	$	1,889	$	19,858
Net income	$	9,694		$	67,430	$	47,429

Denominator:
Basic weighted average shares outstanding	103,848			103,611		103,135
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	629			637		1,048
Diluted weighted average shares outstanding	104,477			104,248		104,183

Basic net income (loss) per common share:
Continuing operations	$	0.79		$	0.63	$	0.27
Discontinued operations	(0.70		)	0.02		0.19
Basic net income per common share	$	0.09		$	0.65	$	0.46

Diluted net income (loss) per common share:
Continuing operations	$	0.79		$	0.63	$	0.26
Discontinued operations	(0.70		)	0.02		0.19
Diluted net income per common share	$	0.09		$	0.65	$	0.46

Basic earnings per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units. Diluted earnings per share includes the dilutive effects of common stock equivalents such as stock options and unvested restricted stock awards. The Company used income from continuing operations as the control number in determining whether potential common shares were dilutive or anti-dilutive. The same number of potential common shares used in computing the diluted per share amount from continuing operations was also used in computing the diluted per share amounts from discontinued operations even if those amounts were anti-dilutive.

There were 560, 271 and 282 stock-based awards excluded from our diluted earnings per share calculations for the fiscal years ended June 30, 2018, 2017 and 2016, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. Additionally, 4 and 12 restricted stock awards were excluded from our diluted earnings per share calculation for the fiscal years ended June 30, 2018 and 2017, as such awards were antidilutive. There were no antidilutive awards excluded from our diluted earnings per share calculations for the fiscal year ended June 30, 2016.

Share Repurchase Program

On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250,000 of the Company’s issued and

outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations, including the Company’s historical strategy of pursuing accretive acquisitions. The Company did not repurchase any shares under this program in fiscal 2018 or 2017, and accordingly, as of the end of fiscal 2018, we had $250,000 of remaining capacity under our share repurchase program.

Discontinued Operations

12 Months Ended

Jun. 30, 2018

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

DISCONTINUED OPERATIONS

In March 2018, the Company’s Board of Directors approved a plan to sell all of the operations of the HPPC and Empire operating segments, which are reported in the aggregate as the Hain Pure Protein reportable segment. Collectively, these dispositions represent a strategic shift that will have a major impact on the Company’s operations and financial results and have been accounted for as discontinued operations. The Company is actively marketing the sale of Hain Pure Protein, and a sale is anticipated to occur within twelve months of the Board of Directors’ approval, which occurred in March 2018.

The Company is presenting the operating results and cash flows of Hain Pure Protein within discontinued operations in the current and prior periods. The assets and liabilities of Hain Pure Protein are presented as assets and liabilities of discontinued operations in the Consolidated Balance Sheets for all periods presented.

The fair value of the Hain Pure Protein operating segments was determined based on a combination of the expected net proceeds upon sale and a discounted cash flow analysis. We completed an initial assessment of the assets and liabilities of the Hain Pure Protein operating segments and based on our best estimates as of the date of issuance of financial results for the third quarter of the fiscal year ended June 30, 2018, no impairment was indicated. In the three months ended June 30, 2018, results for HPPC (which comprises the Plainville and FreeBird brands) were below our projections. The fourth quarter results, as well as negative market conditions in the sector, required the Company to reduce the internal projections for the business, which resulted in the Company lowering the projected long-term growth rate and profitability levels for HPPC. Accordingly, the updated projections indicated that the fair value of the HPPC business is below carrying value. As a result, the Company recorded a reserve of $78,464 to adjust the carrying value of Hain Pure Protein to its fair value, less its cost to sell, which is reflected in Net (loss) income from discontinued operations, net of taxes.

The following table presents the major classes of Hain Pure Protein’s line items constituting the “Net (loss) income from discontinued operations, net of tax” in our Consolidated Statements of Income:



	Fiscal Year Ended June 30,
	2018			2017			2016
Net sales	$	509,475		$	509,606		$	492,510
Cost of sales	486,023			487,631			443,842
Gross profit	23,452			21,975			48,668
Asset impairments	78,464			—			—
Selling, general and administrative expense	18,743			19,180			15,740
Other expense	4,699			1,530			1,590
Net (loss) income from discontinued operations before income taxes	(78,454		)	1,265			31,338
(Benefit) provision for income taxes	(5,720		)	(624		)	11,480
Net (loss) income from discontinued operations, net of tax	$	(72,734	)	$	1,889		$	19,858

Included above within (Benefit) provision for income taxes for the year ended June 30, 2018 is a $20,166 deferred tax benefit arising from asset impairment charges and a $12,250 deferred tax liability related to Hain Pure Protein being classified as held for sale.

Assets and liabilities of discontinued operations presented in the Consolidated Balance Sheets as of June 30, 2018 and June 30, 2017 are included in the following table:




Assets	June 30, 2018			June 30, 2017
Cash and cash equivalents	$	6,461		$	9,937
Accounts receivable, less allowance for doubtful accounts	21,616			22,671
Inventories	105,359			85,313
Prepaid expenses and other current assets	5,604			5,866
Total current assets*				123,787
Property, plant and equipment, net	83,776			78,645
Goodwill	41,089			41,089
Trademarks and other intangible assets, net	51,029			52,040
Other assets	4,381			3,330
Total noncurrent assets of discontinued operations*				175,104
Impairments of long-lived assets held for sale	(78,464		)	—
Total assets of discontinued operations	$	240,851		$	298,891

Liabilities
Accounts payable	$	31,762		$	35,943
Accrued expenses and other current liabilities	6,880			2,005
Total current liabilities of discontinued operations*				37,948
Deferred tax liabilities	11,111			23,129
Other noncurrent liabilities	93			193
Total noncurrent liabilities of discontinued operations*				23,322
Total liabilities of discontinued operations	$	49,846		$	61,270

* The assets and liabilities of Hain Pure Protein are classified as current on the June 30, 2018 Consolidated Balance Sheet because it is probable that the sale will occur within the next twelve months of the Board of Directors’ approval.

Acquisitions

12 Months Ended

Jun. 30, 2018

Business Combinations [Abstract]

Acquisitions

ACQUISITIONS

The Company accounts for acquisitions in accordance with ASC 805, Business Combinations. The results of operations of the acquisitions have been included in the consolidated results from their respective dates of acquisition. The purchase price of each acquisition is allocated to the tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair values. Acquisitions may include contingent consideration, the fair value of which is estimated on the acquisition date as the present value of the expected contingent payments, determined using weighted probabilities of possible payments. The fair values assigned to identifiable intangible assets acquired were determined primarily by using an income approach which was based on assumptions and estimates made by management. Significant assumptions utilized in the income approach were based on Company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by authoritative guidance. The excess of the purchase price over the fair value of the identified assets and liabilities has been recorded as goodwill.

The costs related to all acquisitions have been expensed as incurred and are included in “Acquisition related expenses, restructuring, integration and other charges” in the Consolidated Statements of Income. Acquisition-related costs of $409, $2,035 and $3,679 were expensed in the fiscal years ended June 30, 2018, 2017 and 2016, respectively. The expenses incurred primarily related to professional fees and other transaction related costs associated with our recent acquisitions.

Fiscal 2018

On December 1, 2017, the Company acquired Clarks UK Limited (“Clarks”), a leading maple syrup and natural sweetener brand in the United Kingdom. Clarks produces natural sweeteners under the Clarks^TM brand, including maple syrup, honey and carob, date and agave syrups, which are sold in leading retailers and used by food service and industrial customers in the United Kingdom. Consideration for the transaction, inclusive of a subsequent working capital adjustment, consisted of cash, net of cash acquired, totaling £9,179 (approximately $12,368 at the transaction date exchange rate). Additionally, contingent consideration of up to a maximum of £1,500 is payable based on the achievement of specified operating results over the 18-month period following completion of the acquisition. Clarks is included in our United Kingdom operating segment. The purchase price allocation is based upon a preliminary valuation, and the Company’s estimates and assumptions are subject to change within the measurement period as valuation is finalized. Net sales and income before income taxes attributable to the Clarks acquisition included in our consolidated results represented less than 1% of our consolidated results.

Fiscal 2017

On June 19, 2017, the Company acquired Sonmundo, Inc. d/b/a The Better Bean Company (“Better Bean”), which offers prepared beans and bean-based dips sold in refrigerated tubs under the Better Bean^TM brand. Consideration for the transaction consisted of cash, net of cash acquired, totaling $3,434. Additionally, contingent consideration of up to a maximum of $4,000 is payable based on the achievement of specified operating results over the three-year period following the closing date. Better Bean is included in our Cultivate operating segment, which is part of Rest of World. Net sales and income before income taxes attributable to the Better Bean acquisition and included in our consolidated results were less than 1% of consolidated results.

On April 28, 2017, the Company acquired The Yorkshire Provender Limited (“Yorkshire Provender”), a producer of premium branded soups based in North Yorkshire in the United Kingdom. Yorkshire Provender supplies leading retailers, on-the-go food outlets and food service providers in the United Kingdom. Consideration for the transaction consisted of cash, net of cash acquired, totaling £12,465 (approximately $16,110 at the transaction date exchange rate). Additionally, contingent consideration of up to a maximum of £1,500 is payable based on the achievement of specified operating results at the end of the three-year period following the closing date. Yorkshire Provender is included in our United Kingdom operating and reportable segment. Net sales and income before income taxes attributable to Yorkshire Provender and included in our consolidated results were less than 1% of consolidated results.

Fiscal 2016

On December 21, 2015, the Company acquired Orchard House Foods Limited (“Orchard House”), a leader in pre-cut fresh fruit, juices, fruit desserts and ingredients with facilities in Corby and Gateshead in the United Kingdom. Orchard House supplies leading retailers, on-the-go food outlets, food service providers and manufacturers in the United Kingdom. Consideration for the transaction consisted of cash, net of cash acquired, totaling £76,923 (approximately $114,113 at the transaction date exchange rate). The acquisition was funded with borrowings under the Credit Agreement (as defined in Note 11, Debt and Borrowings). Additionally, contingent consideration of up to £3,000 was potentially payable to the sellers based on the outcome of a review by the Competition and Markets Authority (“CMA”) in the United Kingdom. As a result of this review, the Company agreed to divest certain portions of its own-label juice business in the fourth quarter of fiscal 2016. On September 15, 2017, the contingent consideration obligation referenced above was settled in the amount of £1,500. Orchard House is included in the United Kingdom operating and reportable segment. Net sales and income before income taxes attributable to the Orchard House acquisition and included in our consolidated results were $88,580 and $4,622, respectively, for the fiscal year ended June 30, 2016.

On July 24, 2015, the Company acquired Formatio Beratungs- und Beteiligungs GmbH and its subsidiaries (“Mona”), a leader in plant-based foods and beverages with facilities in Germany and Austria. Mona offers a wide range of organic and natural products under the Joya^® and Happy^® brands, including soy, oat, rice and nut based drinks as well as plant-based yogurts, desserts, creamers, tofu and private label products, sold to leading retailers in Europe, primarily in Austria and Germany and eastern European countries. Consideration for the transaction consisted of cash, net of cash acquired, totaling €22,753 (approximately $24,948 at the transaction date exchange rate) and 240 shares of the Company’s common stock valued at $16,308. Also included in the acquisition was the assumption of net debt totaling €16,252. The cash portion of the purchase price was funded with borrowings under our Credit Agreement. Mona is included in the Europe operating segment which is part of Rest of World. Net sales and income before income taxes attributable to the Mona acquisition and included in our consolidated results were $58,767 and $3,464, respectively, for the fiscal year ended June 30, 2016.

The fair values assigned to identifiable intangible assets acquired were based on assumptions and estimates made by management. Identifiable intangible assets acquired consisted of customer relationships valued at $58,726 with a weighted average estimated useful life of 15 years and trade names valued at $10,965 with indefinite lives. The acquisition resulted in goodwill, which represents the future economic benefits expected to arise that could not be individually identified and separately recognized, including use of the Company’s existing infrastructure to expand sales of the acquired business’ products and to expand sales of the Company’s existing products into new regions. The goodwill recorded as a result of these acquisitions is not expected to be deductible for tax purposes.

The following table provides unaudited pro forma results of continuing operations for the fiscal years ended June 30, 2016 as if the acquisitions of Orchard House and Mona had been completed at the beginning of fiscal 2016. The information has been provided for illustrative purposes only and does not purport to be indicative of the actual results that would have been achieved by the Company for the periods presented or that will be achieved by the combined company in the future. The pro forma information has been adjusted to give effect to items that are directly attributable to the transactions and are expected to have a continuing impact on the combined results.



	Fiscal Year Ended
	June 30, 2016
Net sales from continuing operations	$	2,481,362
Net income from continuing operations	$	31,412
Net income per common share from continuing operations - diluted	$	0.30

Inventories

12 Months Ended

Jun. 30, 2018

Inventory, Net [Abstract]

Inventories

INVENTORIES

Inventories consisted of the following:



	June 30, 2018		June 30, 2017
Finished goods	$	231,926	$	214,547
Raw materials, work-in-progress and packaging	159,599		127,448
	$	391,525	$	341,995

At each period end, inventory is reviewed to ensure that it is recorded at the lower of cost or net realizable value. In the third quarter of fiscal 2018, the Company recorded an inventory write-down of $4,913 in connection with the discontinuance of slow moving SKUs as part of a product rationalization initiative.

Property, Plant and Equipment, Net

12 Months Ended

Jun. 30, 2018

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment, Net

PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:



	June 30, 2018		June 30, 2017
Land	$	28,378	$	28,092
Buildings and improvements	83,289		83,648
Machinery and equipment	323,348		300,750
Computer hardware and software	54,092		50,773
Furniture and fixtures	17,894		15,613
Leasehold improvements	31,519		29,296
Construction in progress	17,280		11,134
	555,800		519,306
Less: Accumulated depreciation	245,628		227,440
	$	310,172	$	291,866

Depreciation expense for the fiscal years ended June 30, 2018, 2017, and 2016 was $33,973, $33,558 and $32,641, respectively.

During fiscal 2018, the Company determined that it was more likely than not that certain fixed assets at three of its manufacturing facilities would be sold or otherwise disposed of before the end of their estimated useful lives due to the Company’s decision to utilize third-party manufacturers for two facilities in the United States and to consolidate manufacturing of certain soup products in the United Kingdom. As such, the Company recorded a $6,344 non-cash impairment charge primarily related to the closures of these facilities and included $3,767 as assets held for sale within “Prepaid expenses and other current assets” in its June 30, 2018 Consolidated Balance Sheet. In connection with the planned closure of the facility in the United Kingdom, the Company expects to incur up to approximately $4,800 over the next twelve months, consisting primarily of costs associated with the early termination of an existing operating lease and employee severance costs.

Additionally, the Company discontinued additional slow moving SKUs in the United States as part of a product rationalization initiative. As a result, expected future cash flows are not expected to support the carrying value of certain machinery and equipment used to manufacture these products. As such, the Company recorded a $2,057 non-cash impairment charge to write down the value of these assets to fair value and included $686 as assets held for sale within “Prepaid expenses and other current assets” in its June 30, 2018 Consolidated Balance Sheet.

In fiscal 2017, the Company determined that it was more likely than not that certain fixed assets at one of its manufacturing facilities in the United Kingdom would be sold or otherwise disposed of before the end of their estimated useful lives due to the Company’s decision to exit its own-label chilled desserts business over the next twelve months. As such, the Company recorded a $23,712 non-cash impairment charge related to the long-lived assets associated with the own-label chilled desserts business to their estimated fair values, which was equal to its salvage value. Additionally, the Company recorded a $2,661 non-cash impairment charge related to fixed assets in the United States.

In fiscal 2016, the Company recorded a $3,476 non-cash impairment charge related to long-lived assets associated with the divestiture of certain portions of its own-label juice business in connection with its acquisition of Orchard House in the United Kingdom.

Goodwill and Other Intangible Assets

12 Months Ended

Jun. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table shows the changes in the carrying amount of goodwill by business segment:



	United States			United Kingdom			Rest of World			Total
Balance as of June 30, 2016 (a)	$	605,702		$	332,561		$	80,984		$	1,019,247
Acquisition activity	—			6,962			3,083			10,045
Reallocation of goodwill between reporting units (b)	(16,377		)	—			16,377			—
Translation and other adjustments, net	(992		)	(10,388		)	980			(10,400		)
Balance as of June 30, 2017 (a)	588,333			329,135			101,424			1,018,892
Acquisition activity	—			7,062			—			7,062
Reallocation of goodwill between reporting units (c)	(35,519		)	35,519			—			—
Impairment charge	—			—			(7,700		)	(7,700		)
Translation and other adjustments, net	—			5,447			435			5,882
Balance as of June 30, 2018 (d)	$	552,814		$	377,163		$	94,159		$	1,024,136

(a) The total carrying value of goodwill is reflected net of $126,577 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment and $29,219 related to the Company’s Europe operating segment.

(b) Effective July 1, 2016, due to changes to the Company’s internal management and reporting structure resulting from the formation of Cultivate, certain brands previously included within the United States operating segment were moved to Cultivate, a new operating segment. Goodwill of $16,377 was reallocated to Rest of World in connection with this change.

(c) Effective July 1, 2017, due to changes to the Company’s internal management and reporting structure, the United Kingdom operations of the Ella’s Kitchen® brand, which was previously included within the United States reportable segment, was moved to the United Kingdom reportable segment. Goodwill totaling $35,519 was reallocated to the United Kingdom reportable segment in connection with this change. The change in operating segments was deemed a triggering event, resulting in the Company performing an interim goodwill impairment analysis on the reporting units impacted by this segment change as of immediately before and immediately after the change. There were no impairment indicators resulting from this analysis, which was performed in the first quarter of fiscal 2018. See Note 1, Business, and Note 19, Segment Information, for additional information on the Company’s operating and reportable segments.

(d) The total carrying value of goodwill is reflected net of $134,277 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment, $29,219 related to the Company’s Europe operating segment and $7,700 related to the Company’s Cultivate operating segment.

Additions during the fiscal year ended June 30, 2018 were due to the acquisition of Clarks on December 1, 2017. The additions during fiscal year ended June 30, 2017 were due to the acquisitions of Better Bean and Yorkshire Provender on June 19, 2017 and April 28, 2017, respectively.

Beginning in the third quarter of fiscal 2018, operations of Hain Pure Protein have been classified as discontinued operations as discussed in Note 5, Discontinued Operations. Therefore, goodwill associated with Hain Pure Protein is presented as assets of discontinued operations in the consolidated financial statements.

The Company completed its annual goodwill impairment analysis in the fourth quarter of fiscal 2018, in conjunction with its budgeting and forecasting process for fiscal year 2019, and concluded that no indicators of impairment existed at any of its reporting units except for its Cultivate reporting unit, which is included in the Rest of World. Based on the step one analysis performed, the Company concluded that the fair value of the Cultivate reporting unit was below its carrying value, indicating that the second step of the impairment test was necessary. The decline in the estimated fair value in the Cultivate reporting unit was primarily the result of lowered projected long-term revenue growth rates and profitability levels. Under the second step, the carrying value of the Cultivate reporting unit’s goodwill was compared to the implied fair value of that goodwill. The implied fair value of goodwill was determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit’s goodwill. As a result of the allocation, the carrying value of goodwill exceeded its residual fair value. Accordingly, the Company recognized goodwill impairment of $7,700 in the fiscal year ended June 30, 2018.

As indicators of impairment existed within the Cultivate reporting unit, the Company performed an assessment of the recoverability for other long-lived assets, such as property, plant and equipment and finite-lived intangibles assets, namely customer relationships. The Company performed an assessment of the recoverability in accordance with the general valuation requirements set forth under ASC Topic 360 - Accounting for the Impairment of Long-Lived Assets. The result of this assessment indicated that no impairment existed for these assets.

Other Intangible Assets

The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization:



	June 30, 2018			June 30, 2017
Non-amortized intangible assets:
Trademarks and trade names (a)	$	385,609		$	384,917
Amortized intangible assets:
Other intangibles	239,323			232,112
Less: accumulated amortization	(114,545		)	(95,801		)
Net carrying amount	$	510,387		$	521,228

(a) The gross carrying value of trademarks and trade names is reflected net of $65,834 and $60,202 of accumulated impairment charges for the fiscal years ended June 30, 2018 and 2017, respectively.

Indefinite-lived intangible assets, which are not amortized, consist primarily of acquired trade names and trademarks. Indefinite-lived intangible assets are evaluated on an annual basis in conjunction with the Company’s evaluation of goodwill. In assessing fair value, the Company utilizes a “relief from royalty” methodology. This approach involves two steps: (i) estimating the royalty rates for each trademark and (ii) applying these royalty rates to a projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying value of the indefinite-lived intangible assets exceeds the fair value of the asset, the carrying value is written down to fair value in the period identified. The result of this assessment for the year ended June 30, 2018 indicated that the fair value of certain of the Company’s trade names was below their carrying value, and therefore an impairment charge of $5,632 was recognized ($5,100 in the Rest of World and $532 in the United Kingdom segment) during the fiscal year ended June 30, 2018. During the fiscal year ended June 30, 2017, an impairment charge of $14,079 ($7,579 in the United Kingdom segment and $6,500 in the United States segment) related to certain of the Company’s trade names was recognized.

Amortizable intangible assets, which are deemed to have a finite life, primarily consist of customer relationships and are being amortized over their estimated useful lives of 3 to 25 years. Amortization expense included in continuing operations was as follows:



	Fiscal Year Ended June 30,
	2018		2017		2016
Amortization of intangible assets	$	18,202	$	16,988	$	17,544

Expected amortization expense over the next five fiscal years is as follows:



	Fiscal Year Ending June 30,
	2019		2020		2021		2022		2023
Estimated amortization expense	$	15,675	$	14,379	$	13,913	$	13,209	$	12,620

The weighted average remaining amortization period of amortized intangible assets is 10.1 years.

Accrued Expenses and Other Current Liabilities

12 Months Ended

Jun. 30, 2018

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:



	June 30, 2018		June 30, 2017
Payroll, employee benefits and other administrative accruals	$	75,918	$	68,658
Facility, freight and warehousing accruals	20,970		20,019
Selling and marketing related accruals	15,546		9,734
Other accruals	3,567		8,316
	$	116,001	$	106,727

Debt and Borrowings

12 Months Ended

Jun. 30, 2018

Debt Disclosure [Abstract]

Debt and Borrowings

DEBT AND BORROWINGS

Debt and borrowings consisted of the following:



	June 30, 2018			June 30, 2017
Unsecured revolving credit facility	$	401,852		$	733,715
Term loan	296,250			—
Less: Unamortized issuance costs	(692		)	—
Tilda short-term borrowing arrangements	9,338			7,761
Other borrowings	7,358			8,285
	714,106			749,761
Short-term borrowings and current portion of long-term debt	26,605			9,626
Long-term debt, less current portion	$	687,501		$	740,135

Credit Agreement

On February 6, 2018, the Company entered into the Third Amended and Restated Credit Agreement (the “Credit Agreement”), which amended and restated the Second Amended and Restated Credit Agreement. The Credit Agreement provides for the extension of the Company’s existing $1,000,000 unsecured revolving credit facility through February 6, 2023 and provides for a $300,000 term loan. Under the Credit Agreement, the credit facility may be increased by an additional uncommitted $400,000, provided certain conditions are met.

Borrowings under the Credit Agreement may be used to provide working capital, finance capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other lawful corporate purposes. The Credit Agreement provides for multicurrency borrowings in Euros, Pounds Sterling and Canadian Dollars as well as other currencies which may be designated. In addition, certain wholly-owned foreign subsidiaries of the Company may be designated as co-borrowers. The Credit Agreement contains restrictive covenants, which are usual and customary for facilities of its type, and include, with specified exceptions, limitations on the Company’s ability to engage in certain business activities, incur debt, have liens, make capital expenditures, pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans. The Credit Agreement also requires the Company to satisfy certain financial covenants, such as maintaining a consolidated interest coverage ratio (as defined in the Credit Agreement) of no less than 4.0 to 1.0 and a consolidated leverage ratio (as defined in the Credit Agreement) of no more than 3.5 to 1.0. The consolidated leverage ratio is subject to a step-up to 4.0 to 1.0 for the four full fiscal quarters following an acquisition. Obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company. As of June 30, 2018, there were $401,852 and $296,250 of borrowings outstanding under the unsecured credit facility and term loan, respectively, and $8,976 letters of credit outstanding under the Credit Agreement. As of June 30, 2018, $589,172 was available under the Credit Agreement, and the Company was in compliance with all associated covenants.

The Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in the Credit Agreement, plus a rate ranging from 0.875% to 1.70% per annum; or (b) the Base Rate, as defined in the Credit Agreement, plus a rate ranging from 0.00% to 0.70% per annum, the relevant rate being the Applicable Rate. The Applicable Rate will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. Swing line loans and Global Swing Line loans denominated in U.S. dollars will bear interest at the Base Rate plus the Applicable Rate, and Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight Eurocurrency Rate for loans denominated in such currency plus the Applicable Rate. The weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2018 was 3.51%. Additionally, the Credit Agreement contains a Commitment Fee, as defined in the Credit Agreement, on the amount unused under the Credit Agreement ranging from 0.20% to 0.30% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

The term loan has required installment payments due on the last day of each fiscal quarter commencing June 30, 2018 in an amount equal to $3,750 and can be prepaid in whole or in part without premium or penalty.

Credit Agreement Issuance Costs

The Company incurred debt issuance costs of approximately $3,646 in connection with the Credit Agreement, which were deferred and are being amortized as interest expense over the term of the Credit Agreement. Of these deferred debt issuance costs, $2,891 were associated with the revolving credit facility and are being amortized on a straight-line basis within other assets on the Company’s Consolidated Balance Sheet, and $755 are being amortized on a straight-line basis, which approximates the effective interest method, as an adjustment to the carrying amount of term loan as a component of interest expense.

Tilda Short-Term Borrowing Arrangements

Tilda, a component of the Company’s United Kingdom reportable segment, maintains short-term borrowing arrangements primarily used to fund the purchase of rice from India and other countries. The maximum borrowings permitted under all such arrangements are £52,000. Outstanding borrowings are collateralized by the current assets of Tilda, typically have six-month terms and bear interest at variable rates typically based on LIBOR plus a margin (weighted average interest rate of approximately 3.92% at June 30, 2018). As of June 30, 2018, there were $9,338 of borrowings under these arrangements.

Other Borrowings

Other borrowings include a cash pool facility in Europe and an uncommitted revolving credit facility in India.

The cash pool facility provides our Europe operating segment with sufficient liquidity to support the Company’s growth objectives within this segment. The maximum borrowings permitted under the cash pool arrangement are €12,500. Outstanding borrowings bear interest at variable rates typically based on EURIBOR plus a margin of 1.10% (weighted average interest rate of approximately 1.10% at June 30, 2018). As of June 30, 2018, there were $316 of borrowings under this facility.

During the third quarter of fiscal 2018, Tilda Hain India Private Limited, our subsidiary residing in India, entered into an uncommitted revolving credit facility to fund its working capital needs. The maximum borrowings permitted under the arrangement are $4,000. There were no amounts outstanding at June 30, 2018.

Maturities of all debt instruments at June 30, 2018, are as follows:



Due in Fiscal Year	Amount
2019	$	26,605
2020	16,988
2021	16,857
2022	15,339
2023	638,154
Thereafter	163
	$	714,106

Interest paid during the fiscal years ended June 30, 2018, 2017 and 2016 amounted to $24,168, $18,819 and $24,208, respectively.

Income Taxes

12 Months Ended

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

The components of income (loss) before income taxes and equity in earnings of equity-method investees were as follows:



	Fiscal Year Ended June 30,
	2018			2017		2016
Domestic	$	(13,936	)	$	47,781	$	126,686
Foreign	95,138			40,097		(39,617		)
Total	$	81,202		$	87,878	$	87,069

The provision (benefit) for income taxes consisted of the following:



	Fiscal Year Ended June 30,
	2018			2017			2016
Current:
Federal	$	(1,309	)	$	18,331		$	9,953
State and local	1,383			(293		)	1,668
Foreign	20,542			14,884			14,737
	20,616			32,922			26,358
Deferred:
Federal	(22,612		)	(3,198		)	30,711
State and local	1,973			960			5,017
Foreign	(864		)	(8,218		)	(2,635		)
	(21,503		)	(10,456		)	33,093
Total	$	(887	)	$	22,466		$	59,451

For the fiscal year ended June 30, 2018, the Company paid cash for income taxes, net of refunds of $24,284. Cash paid for income taxes, net of (refunds), during the fiscal years ended June 30, 2017 and 2016 amounted to $(2,900) and $44,225, respectively.

The reconciliation of the U.S. federal statutory rate to our effective rate on income before provision for income taxes was as follows:



	Fiscal Year Ended June 30,
	2018			%		2017			%		2016			%
Expected United States federal income tax at statutory rate	$	22,818		28.1	%	$	30,757		35.0	%	$	30,474		35.0	%
State income taxes, net of federal benefit	2,774			3.4	%	2,757			3.1	%	4,263			4.9	%
Domestic manufacturing deduction	—			—	%	(846		)	(1.0	)%	(505		)	(0.6	)%
Foreign income at different rates	(7,174		)	(8.8	)%	(6,539		)	(7.4	)%	(4,051		)	(4.7	)%
Impairment of goodwill and intangibles	1,816			2.2	%	—			—	%	23,172			26.6	%
Change in valuation allowance	119			0.1	%	(60		)	(0.1	)%	5,067			5.8	%
Corporate tax reorganization	—			—	%	—			—	%	(4,173		)	(4.8	)%
Unrealized foreign exchange losses	—			—	%	807			0.9	%	7,056			8.1	%
Change in reserves for uncertain tax positions	(3,859		)	(4.8	)%	(4,417		)	(5.0	)%	1,448			1.7	%
Tax Act’s transition tax (b)	7,054			8.7	%	—			—	%	—			—	%
Tax Act’s impact of deferred taxes (a)	(25,006		)	(30.8	)%	—			—	%	—			—	%
Reduction of deferred tax liabilities resulting from change in United Kingdom tax rate	—			—	%	(1,841		)	(2.1	)%	(4,942		)	(5.7	)%
Other	571			0.8	%	1,848			2.2	%	1,642			2.0	%
(Benefit) provision for income taxes	$	(887	)	(1.1	)%	$	22,466		25.6	%	$	59,451		68.3	%

On December 22, 2017, the U.S. government enacted comprehensive tax legislation pursuant to the Tax Cuts and Jobs Act (the “Tax Act”), which significantly revised the ongoing U.S. corporate income tax law by lowering the U.S. federal corporate income tax rate from 35% to 21%, implementing a territorial tax system, imposing a one-time tax on foreign unremitted earnings and setting limitations on deductibility of certain costs (e.g., interest expense), among other things.

Due to the complexities involved in accounting for the Tax Act, the U.S. Securities and Exchange Commission’s Staff Accounting Bulletin (“SAB”) 118 requires that the Company include in its financial statements a reasonable estimate of the impact of the Tax Act on earnings to the extent such reasonable estimate has been determined. Accordingly, the Company recorded the following reasonable estimates of the tax impact in its earnings for the fiscal year ended June 30, 2018.

(a) For the fiscal year ended June 30, 2018, the Company accrued a $25,006 provisional tax benefit related to the net change in deferred tax liabilities stemming from the Tax Act’s reduction of the U.S. federal tax rate from 35% to 21%, and disallowance of certain incentive based compensation tax deductibility under Internal Revenue Code Section 162(m).

(b) For the fiscal year ended June 30, 2018, the Company accrued a reasonable estimate of $7,054 of tax expense for the Tax Act’s one-time transition tax on the foreign subsidiaries’ accumulated, unremitted earnings going back to 1986.

The final impact on the Company from the Tax Act’s transition tax legislation may differ from the aforementioned reasonable estimate of $7,054 due to the complexity of calculating and supporting with primary evidence such U.S. tax attributes as accumulated foreign earnings and profits, foreign tax paid and other tax components involved in foreign tax credit calculations for prior years back to 1986. Such differences could be material, due to, among other things, changes in interpretations of the Tax Act, future legislative action to address questions that arise because of the Tax Act, changes in accounting standards for income taxes or related interpretations in response to the Tax Act, or any updates or changes to estimates the Company has utilized to calculate the transition tax's reasonable estimate.

Pursuant to SAB 118, the Company is allowed a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts. The Company will continue to calculate the impact of the Tax Act and will record any resulting tax adjustments during fiscal 2019. Additionally, the Company will elect to pay the transition tax in installments over a period of 8 years, pursuant to the guidance of the new Internal Revenue Code Section 965.

The Tax Act also includes a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries. The Company will be subject to the GILTI provisions effective beginning July 1, 2018 and is in the process of analyzing its effects, including how to account for the GILTI provision from an accounting policy standpoint.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Deferred tax assets and liabilities consisted of the following:



	June 30, 2018			June 30, 2017
Noncurrent deferred tax assets/(liabilities):
Basis difference on inventory	$	9,139		$	9,003
Reserves not currently deductible	11,060			23,111
Basis difference on intangible assets	(97,365		)	(124,756		)
Basis difference on property and equipment	(8,444		)	(12,086		)
Other comprehensive income	(133		)	(768		)
Net operating loss and tax credit carryforwards	12,414			19,049
Stock-based compensation	1,348			3,996
Other	41			(616		)
Valuation allowances	(14,969		)	(14,850		)
Noncurrent deferred tax liabilities, net (1)	$	(86,909	)	$	(97,917	)


(1)	The June 30, 2017 the Consolidated Balance Sheet includes $429 of non-current deferred tax assets in Other Assets.

At June 30, 2018 and 2017, the Company had U.S. federal net operating loss (“NOL”) carryforwards of approximately $23,057 and $25,144, respectively, the majority of which will not expire until 2033. Certain of these federal loss carryforwards are subject to Internal Revenue Code Section 382 which imposes limitations on utilization following certain changes in ownership of the entity generating the loss carryforward. The Company had foreign NOL carryforwards of approximately $30,065 and $43,306 at June 30, 2018 and 2017, respectively, the majority of which are indefinite lived.

At each of June 30, 2018 and 2017, the Company had U.S. federal foreign tax credit carryforwards of approximately $877, which have various expiration dates through 2020.

As of June 30, 2018, the Company has not provided for deferred taxes on the excess of financial reporting over the tax basis of investments in certain foreign subsidiaries in the amount of $32,967 as the Company plans to reinvest such earnings indefinitely outside the United States. If these earnings were repatriated in the future, additional income and withholding tax expense would be incurred. Due to complexities in the laws of the U.S. and foreign jurisdictions and the assumptions that would have to be made, it is not practicable to estimate the total amount of income taxes that would have to be provided on such earnings.

As required by the authoritative guidance on accounting for income taxes, the Company evaluates the realizability of deferred tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes requires that a valuation allowance be established when it is more likely than not that all or a portion of the deferred tax assets will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred tax assets are not more likely than not realizable, we establish a valuation allowance. We have recorded valuation allowances in the amounts of $14,969 and $14,850 at June 30, 2018 and 2017, respectively.

The changes in valuation allowances against deferred income tax assets were as follows:



	Fiscal Year Ended June 30,
	2018			2017
Balance at beginning of year	$	14,850		$	15,310
Additions charged to income tax expense	1,251			1,862
Reductions credited to income tax expense	(1,345		)	(1,922		)
Currency translation adjustments	213			(400		)
Balance at end of year	$	14,969		$	14,850

Unrecognized tax benefits activity, including interest and penalties, is summarized below:



	Fiscal Year Ended June 30,
	2018			2017			2016
Balance at beginning of year	$	11,602		$	16,019		$	10,759
Additions based on tax positions related to the current year	118			217			4,276
Additions based on tax positions related to prior years	—			—			1,404
Reductions due to lapse in statute of limitations and settlements	(4,990		)	(4,634		)	(420		)
Balance at end of year	$	6,730		$	11,602		$	16,019

As of June 30, 2018, the Company had $6,730 of unrecognized tax benefits, of which $2,917 represents the amount that, if recognized, would impact the effective tax rate in future periods. As of June 30, 2017 and 2016, the Company had $11,602 and $16,019, respectively, of unrecognized tax benefits of which $6,409 and $10,826, respectively, would impact the effective income tax rate in future periods. Accrued liabilities for interest and penalties were $82 and $460 at June 30, 2018 and 2017, respectively. Interest and penalties (expense and/or benefit) are recorded as a component of the provision (benefit) for income taxes in the consolidated financial statements.

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and several foreign jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years prior to fiscal 2015. However, to the extent we generated NOLs or tax credits in closed tax years, future use of the NOL or tax credit carryforward balance would be subject to examination within the relevant statute of limitations for the year in which utilized. The Company is no longer subject to tax examinations in the United Kingdom for years prior to fiscal 2015. Given the uncertainty regarding when tax authorities will complete their examinations and the possible outcomes of their examinations, a current estimate of the range of reasonably possible significant increases or decreases of income tax that may occur within the next twelve months cannot be made. Although there are various tax audits currently ongoing, the Company does not believe the ultimate outcome of such audits will have a material impact on the Company’s consolidated financial statements.

Stockholders' Equity

12 Months Ended

Jun. 30, 2018

Equity [Abstract]

Stockholders' Equity

STOCKHOLDERS’ EQUITY

Preferred Stock

The Company is authorized to issue “blank check” preferred stock of up to 5,000 shares with such designations, rights and preferences as may be determined from time to time by the Board of Directors. Accordingly, the Board of Directors is empowered to issue, without stockholder approval, preferred stock with dividends, liquidation, conversion, voting or other rights which could decrease the amount of earnings and assets available for distribution to holders of the Company’s Common Stock. At June 30, 2018 and 2017, no preferred stock was issued or outstanding.

Accumulated Other Comprehensive Income (Loss)

The following table present the changes in accumulated other comprehensive income (loss):



	Fiscal Year Ended June 30,
	2018			2017
Foreign currency translation adjustments:
Other comprehensive loss before reclassifications ⁽¹⁾	$	11,497		$	(22,951	)
Deferred gains/(losses) on cash flow hedging instruments:
Other comprehensive income before reclassifications	39			196
Amounts reclassified into income ⁽²⁾	(106		)	(575		)
Unrealized gain on available for sale investment:
Other comprehensive loss before reclassifications	(191		)	(51		)
Amounts reclassified into income ⁽³⁾	—			13
Net change in accumulated other comprehensive income (loss)	$	11,239		$	(23,368	)


(1)	Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were a gain of $493 and a loss of $18,385 for the fiscal years ended June 30, 2018 and 2017, respectively.


(2)	Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $132 and $1,233 for the fiscal years ended June 30, 2018 and 2017, respectively.

(3)

Amounts reclassified into income for gains on sale of available for sale investments were based on the average cost of the shares held (See Note 15, Investments and Joint Ventures). Such amounts are recorded in “Other (income)/expense, net” in the Consolidated Statements of Income and was $21 before taxes for the fiscal year ended June 30, 2017. There were no amounts reclassified into income for the fiscal year ended June 30, 2018.

Stock-Based Compensation and Incentive Performance Plans

12 Months Ended

Jun. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation and Incentive Performance Plans

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

The Company has two shareholder-approved plans, the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan and the 2000 Directors Stock Plan, under which the Company’s officers, senior management, other key employees, consultants and directors may be granted options to purchase the Company’s common stock or other forms of equity-based awards.

2002 Long-Term Incentive and Stock Award Plan, as amended

In November 2002, our stockholders approved the 2002 Long-Term Incentive and Stock Award Plan. An aggregate of 3,200 shares of common stock were originally reserved for issuance under this plan. At various Annual Meetings of Stockholders, including the 2014 Annual Meeting, the plan was amended to increase the number of shares issuable to 31,500 shares. The plan provides for the granting of stock options, stock appreciation rights, restricted stock, restricted share units, performance shares, performance share units and other equity awards to employees, directors and consultants. Awards denominated in shares of common stock other than options and stock appreciation rights will be counted against the available share limit as two and seven hundredths shares for every one share covered by such award. All of the options granted to date under the plan have been incentive or non-qualified stock options providing for the exercise price equal to the fair market price at the date of grant. Stock option awards granted under the plan expire seven years after the date of grant. Options and other stock-based awards vest in accordance with provisions set forth in the applicable award agreements. No awards shall be granted under this plan after November 20, 2024. As of June 30, 2018, no options are outstanding under the plan.

There were no options granted under this plan in fiscal years 2018, 2017 or 2016.

There were 685, 195 and 498 shares of restricted stock and restricted share units granted under this plan during fiscal years 2018, 2017 and 2016, respectively. Included in these grants during fiscal years 2018, 2017 and 2016 were 307, 0 and 366, respectively, of restricted stock and restricted share units granted under the Company’s long-term incentive programs, of which 307, 0 and 284, respectively, are subject to the achievement of minimum performance goals established under those programs (see “Long-Term Incentive Plan,” in this Note 14) or market conditions.

At June 30, 2018, 1,057 unvested restricted stock and restricted share units were outstanding under this plan, and there were 10,495 shares available for grant under this plan. At June 30, 2018, there were no options outstanding under this plan.

2000 Directors Stock Plan, as amended

In May 2000, our stockholders approved the 2000 Directors Stock Plan. The plan originally provided for the granting of stock options to non-employee directors to purchase up to an aggregate of 1,500 shares of our common stock. In December 2003, the plan was amended to increase the number of shares issuable to 1,900 shares. In March 2009, the plan was amended to permit the granting of restricted stock, restricted share units and dividend equivalents and was renamed. All of the options granted to date under this plan have been non-qualified stock options providing for the exercise price equal to the fair market price at the date of grant. Stock option awards granted under the plan expire seven years after the date of grant. No awards shall be granted under this plan after December 1, 2015.

There were no options granted under this plan in fiscal years 2018, 2017 or 2016.

There were no shares of restricted stock granted under this plan during fiscal years 2018 and 2017. At June 30, 2018, no unvested restricted shares were outstanding, and there will be no further restricted shares or options granted under this plan.

Other Plans

At June 30, 2018, there were 122 options outstanding that were granted under the prior Celestial Seasonings plan.

Although no further awards can be granted under the 2000 Directors Stock Plan, as amended, or the prior Celestial Seasonings plan, the options and restricted stock outstanding continue in accordance with the terms of the respective plans and grants.

There were 11,678 shares of common stock reserved for future issuance in connection with stock-based awards as of June 30, 2018.

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock-based compensation plans were as follows:



	Fiscal Year Ended June 30,
	2018		2017		2016
Compensation cost (included in selling, general and administrative expense)	$	11,177	$	9,658	$	12,688
Related income tax benefit	$	2,165	$	3,622	$	4,758

Stock-based compensation expense for the fiscal year ended June 30, 2018 included a net reduction of $2,222 in connection with the modification of Irwin D. Simon’s total share return (“TSR”) performance based awards granted on September 26, 2017. Refer to Note 3, Chief Executive Officer Succession Plan, for further discussion.

Stock Options

A summary of the stock option activity for the three fiscal years ended June 30 is as follows:



	2018	Weighted Average Exercise Price		2017		Weighted Average Exercise Price		2016		Weighted Average Exercise Price
Outstanding at beginning of year	122	$	2.26	342		$	6.66	1,249		$	6.12
Exercised	—	$	—	(220	)	$	9.10	(907	)	$	5.91
Outstanding at end of year	122	$	2.26	122		$	2.26	342		$	6.66

Options exercisable at end of year	122	$	2.26	122		$	2.26	342		$	6.66



	Fiscal Year Ended June 30,
	2018		2017		2016
Intrinsic value of options exercised	$	—	$	6,507	$	27,147
Cash received from stock option exercises	$	—	$	—	$	—
Tax benefit recognized from stock option exercises	$	—	$	2,538	$	10,587

For options outstanding and exercisable at June 30, 2018, the aggregate intrinsic value (the difference between the closing stock price on the last day of trading in the year and the exercise price) was $3,358, and the weighted average remaining contractual life was 13.0 years. At June 30, 2018, there was no unrecognized compensation expense related to stock option awards.

Restricted Stock

Awards of restricted stock may be either grants of restricted stock or restricted share units that are issued at no cost to the recipient. For restricted stock grants, at the date of grant the recipient has all rights of a stockholder, subject to certain restrictions on transferability and a risk of forfeiture. For restricted share units, legal ownership of the shares is not transferred to the employee until the unit vests. Restricted stock and restricted share unit grants vest in accordance with provisions set forth in the applicable award agreements, which may include performance criteria for certain grants. The compensation cost of these awards is determined using the fair market value of the Company’s common stock on the date of the grant. Compensation expense for restricted stock awards with a service condition is recognized on a straight-line basis over the vesting term. Compensation expense for restricted stock awards with a performance condition is recorded when the achievement of the performance criteria is probable and is recognized over the performance and vesting service periods.

A summary of the restricted stock and restricted share units activity for the three fiscal years ended June 30 is as follows:



	2018		Weighted Average Grant Date Fair Value (per share)	2017		Weighted Average Grant Date Fair Value (per share)	2016		Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock and restricted share units - beginning of year	992		$27.59	1,121		$28.24	1,145		$32.30
Granted	685		$26.13	195		$33.68	416		$24.54
Vested	(433	)	$36.68	(290	)	$33.89	(408	)	$35.13
Forfeited	(187	)	$31.15	(34	)	$29.88	(32	)	$45.83
Non-vested restricted stock and restricted share units - end of year	1,057		$22.29	992		$27.59	1,121		$28.24

The table above included the impact of the effective forfeiture of 164 TSR shares granted to our CEO on September 26, 2017 (the Company’s first fiscal quarter) at a fair value of $31.60 and a re-grant of 164 TSR shares at a fair value of $3.19 per share in the Company’s fourth fiscal quarter. The lower fair value per share is attributable to the lower likelihood of attainment. Refer to Note 3, Chief Executive Officer Succession Plan, for further discussion.



	Fiscal Year Ended June 30,
	2018		2017		2016
Fair value of restricted stock and restricted share units granted	$	17,898	$	6,567	$	10,203
Fair value of shares vested	$	15,736	$	9,866	$	18,917
Tax benefit recognized from restricted shares vesting	$	5,235	$	3,768	$	7,139

On July 3, 2012, the Company entered into a Restricted Stock Agreement with Irwin D. Simon, the Company’s Chairman, President and Chief Executive Officer. The Restricted Stock Agreement provides for a grant of 800 shares of restricted stock (the “Shares”), the vesting of which is both market and time-based. The market condition is satisfied in increments of 200 Shares upon the Company’s common stock achieving four share price targets. On the last day of any forty-five consecutive trading day period during which the average closing price of the Company’s common stock on the Nasdaq Global Select Market equals or exceeds the following prices: $31.25, $36.25, $41.25 and $50.00, respectively, the market condition for each increment of 200 Shares will be satisfied. The market conditions were required to be satisfied prior to June 30, 2017. Once each market condition has been satisfied, a tranche of 200 Shares will vest in equal amounts annually over a five-year period. Except in the case of a change of control, termination without cause, death or disability (each as defined in Mr. Simon’s Employment Agreement), the unvested Shares are subject to forfeiture unless Mr. Simon remains employed through the applicable market conditions and time vesting periods. The grant date fair value for each tranche was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment and the time frame most likely for goal attainment. The total grant date fair value of the Shares was estimated to be $16,151, which was expected to be recognized over a weighted-average period of approximately 4.0 years. On September 28, 2012, August 27, 2013, December 13, 2013 and October 22, 2014, the four respective market conditions were satisfied. As such, the four tranches of 200 Shares each are expected to vest in equal amounts over the five-year period commencing on the first anniversary of the date the market condition for the respective tranche was satisfied. Under the terms of the Succession Agreement with Mr. Simon executed on June 24, 2018, the fourth tranche will vest on the Succession Date as defined. Refer to Note 3, Chief Executive Officer Succession Plan, for further discussion.

At June 30, 2018, $12,833 of unrecognized stock-based compensation expense, net of estimated forfeitures, related to non-vested restricted stock awards, inclusive of the Shares, was expected to be recognized over a weighted-average period of approximately 1.8 years.

Long-Term Incentive Plan

The Company maintains a long-term incentive program (the “LTI Plan”). The LTI Plan currently consists of two performance-based long-term incentive plans (the “2016-2018 LTIP” and “2017-2019 LTIP”) that provide for a combination of equity grants and performance awards that can be earned over a three-year performance period. Participants in the LTI Plans include the Company’s executive officers, including the CEO, and certain other key executives.

The Compensation Committee administers the LTI Plans and is responsible for, among other items, establishing the target values of awards to participants and selecting the specific performance factors for such awards. The Compensation Committee determines the specific payout to the participants. Such awards may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee, provided that any such stock-based awards shall be issued pursuant to and be subject to the terms and conditions of the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan, as in effect and as amended from time to time.

Upon adoption of the 2016-2018 LTIP and 2017-2019 LTIP, the Compensation Committee granted performance units to each participant, the achievement of which is dependent upon a defined calculation of relative total shareholder return over the period from July 1, 2015 to June 30, 2018 and from July 1, 2017 to June 30, 2019 (the “TSR Grant”), respectively. The grant date fair value for these awards was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment. Each performance unit translates into one unit of common stock. The TSR grant represents half of each participant’s target award. The other half of the 2016-2018 LTIP and 2017-2019 LTIP is based on the Company’s achievement of specified net sales growth targets over the respective three-year period. If the targets are achieved, the award in connection with the 2016-2018 LTIP may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee, while the award in connection with the 2017-2019 LTIP may be paid only in unrestricted shares of the Company’s common stock.

The Company maintained a two-year performance-based long term incentive plan, the 2015-2016 LTIP, whereby the Compensation Committee granted each participant an initial award in the form of equity-based instruments (restricted stock or restricted share units), for a portion of the individual target awards (the “Initial Equity Grants”). These Initial Equity Grants were subject to the achievement of minimum performance goals and vested on a pro rata basis over the three-year period. The 2015-2016 LTIP awards contained an additional year of time-based vesting. The Initial Equity Grants were expensed over the vesting period of three years on a straight-line basis through November 2017.

In October 2015, although the target values previously set under the LTI Plan covering 2014 and 2015 fiscal years (the “2014-2015 LTIP”) were fully achieved, the Compensation Committee exercised its discretion to reduce the awards due to the challenges faced by the Company in connection with the nut butter voluntary recall during fiscal year 2015. After deducting the value of the Initial Equity Grants, the reduced awards to participants related to the 2014-2015 LTIP totaled $4,400 (which were settled by the issuance of 82 unrestricted shares of the Company’s common stock in October 2015).

The Company has recorded expense (in addition to the stock-based compensation expense associated with the Initial Equity Grants and the TSR Grant) of $1,313 and $4,044, for the fiscal years ended June 30, 2018 and 2017, respectively, related to the LTI plans. In the fiscal year ended June 30, 2016, the Company recorded a reversal of expense of $2,037 related to the LTI plans.

Investments and Joint Ventures	12 Months Ended
Investments and Joint Ventures	Jun. 30, 2018
Equity Method Investments and Joint Ventures [Abstract]
Investments and Joint Ventures	INVESTMENTS AND JOINT VENTURES Equity method investments In October 2009, the Company formed a joint venture, Hutchison Hain Organic Holdings Limited (“HHO”), with Hutchison China Meditech Ltd. (“Chi-Med”), a majority-owned subsidiary of CK Hutchison Holdings Limited, to market and distribute certain of the Company’s brands in Hong Kong, China and other surrounding markets. Voting control of the joint venture is shared equally between the Company and Chi-Med, although, in the event of a deadlock, Chi-Med has the ability to cast the deciding vote, and therefore, the investment is being accounted for under the equity method of accounting. At June 30, 2018 and June 30, 2017, the carrying value of the Company’s 50.0% investment in and advances to HHO were $3,020 and $1,629, respectively, and are included in the Consolidated Balance Sheets as a component of “Investments and joint ventures.” On October 27, 2015, the Company acquired a 14.9% interest in Chop’t Creative Salad Company LLC (“Chop’t”). Chop’t develops and operates fast-casual, fresh salad restaurants in the Northeast and Mid-Atlantic United States. Chop’t markets and sells certain of the Company’s branded products and provides consumer insight and feedback. The investment is being accounted for as an equity method investment due to the Company’s representation on the Board of Directors. During fiscal 2018, the Company’s ownership interest was reduced to 13.4% due to the distribution of additional ownership interests. Further ownership interest distributions could potentially dilute the Company’s ownership interest to as low as 11.9%. At June 30, 2018 and June 30, 2017, the carrying value of the Company’s investment in Chop’t was $15,524 and $16,487, respectively, and is included in the Consolidated Balance Sheets as a component of “Investments and joint ventures.” In the fiscal year ended June 30, 2018, the Company made cash contributions of $1,489 to its joint venture, Hain Future Natural Products Private Ltd. (“HFN”). This joint venture is with Future Consumer Ltd (“Future”), which is part of the Future Group, a conglomerate primarily engaged in the consumer and retail business in India. The joint venture was created to market and distribute certain of the Company’s brands in India. Voting control of the joint venture is shared equally between the Company and Future and is being accounted for under the equity method of accounting. At June 30, 2018, the carrying value of the Company’s 50.0% investment in HFN was $1,489 and is included in the Consolidated Balance Sheets as a component of “Investments and joint ventures.” Available-For-Sale Securities The Company has a less than 1% equity ownership interest in Yeo Hiap Seng Limited (“YHS”), a Singapore-based natural food and beverage company listed on the Singapore Exchange, which is accounted for as an available-for-sale security. The Company sold 102 of its YHS shares during the fiscal year ended June 30, 2017, which resulted in a pre-tax loss of $21 on the sales, and is recognized as a component of “Other (income)/expense, net.” No shares were sold during the fiscal year ended June 30, 2018. The shares held at June 30, 2018 totaled 933. The fair value of these shares held was $692 (cost basis of $1,164) at June 30, 2018 and $882 (cost basis of $1,164) at June 30, 2017 and is included in “Investments and joint ventures,” with the related unrealized gain or loss, net of tax, included in “Accumulated other comprehensive loss” in the Consolidated Balance Sheets. The Company concluded that the decline in its YHS investment below its cost basis is temporary and, accordingly, has not recognized a loss in the Consolidated Statements of Income. In making this determination, the Company considered its intent and ability to hold the investment until the cost is recovered, the financial condition and near-term prospects of YHS, the magnitude of the loss compared to the investment’s cost and publicly available information about the industry and geographic region in which YHS operates.

Financial Instruments Measured at Fair Value

12 Months Ended

Jun. 30, 2018

Fair Value Disclosures [Abstract]

Financial Instruments Measured at Fair Value

FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:


•	Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;


•	Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and


•	Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2018:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	99	$	99	$	—	$	—
Forward foreign currency contracts	365		—		365		—
Available for sale securities	692		692		—		—
	$	1,156	$	791	$	365	$	—
Liabilities:
Forward foreign currency contracts	$	27	$	—	$	27	$	—
Contingent consideration, noncurrent	1,909		—		—		1,909
Total	$	1,936	$	—	$	27	$	1,909

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2017:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	21,800	$	21,800	$	—	$	—
Forward foreign currency contracts	99		—		99		—
Available for sale securities	882		882		—		—
	$	22,781	$	22,682	$	99	$	—
Liabilities:
Forward foreign currency contracts	53		—		53		—
Contingent consideration, current	2,656		—		—		2,656
Total	$	2,709	$	—	$	53	$	2,656

Available for sale securities consist of the Company’s investment in YHS (see Note 15, Investments and Joint Ventures). Fair value is measured using the market approach based on quoted prices. The Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices.

The Company estimates the original fair value of the contingent consideration as the present value of the expected contingent payments, determined using the weighted probabilities of the possible payments. The Company reassesses the fair value of contingent payments on a periodic basis. Although the Company believes its estimates and assumptions are reasonable, different assumptions, including those regarding the operating results of the respective businesses, or changes in the future may result in different estimated amounts.

In connection with the acquisition of Belvedere in February 2015, payment of a portion of the respective purchase price was contingent upon the achievement of certain operating results. Contingent consideration of up to a maximum of C$4,000 related to the Belvedere acquisition was payable based on the achievement of specified operating results during the two consecutive one-year periods following the closing date. In both the fourth quarter of fiscal 2017 and 2016, the Company paid C$2,000 in each quarter in settlement of the Belvedere contingent consideration obligation.

In connection with the acquisition of Orchard House during fiscal 2016, contingent consideration of up to £3,000 was potentially payable to the sellers based on the outcome of a review by the CMA in the United Kingdom. As a result of this review, the Company agreed to divest certain portions of its own-label juice business in the fourth quarter of fiscal 2016, and on September 15, 2016, the Company settled the contingent consideration related to this acquisition for £1,500.

In connection with the acquisitions of Better Bean and Yorkshire Provender during fiscal 2017, payments of a portion of the respective purchase prices were contingent upon the achievement of certain operating results. Contingent consideration of up to a maximum of $4,000 related to the Better Bean acquisition is payable based on the achievement of specified operating results over the three years following the closing date. Contingent consideration of up to a maximum of £1,500 related to the Yorkshire Provender acquisition is payable based on the achievement of specified operating results at the end of the three-year period following the closing date.

In connection with the acquisition of Clarks during fiscal 2018, payment of a portion of the purchase price is contingent upon the achievement of certain operating results. Contingent consideration of up to a maximum of £1,500 is payable based on the achievement of specified operating results over the 18-month period following completion of the acquisition.

The following table summarizes the Level 3 activity:



	Fiscal Year Ended June 30,
	2018			2017
Balance at beginning of year	$	2,656		$	3,553
Fair value of initial contingent consideration	1,547			2,652
Contingent consideration adjustment	(2,281		)	526
Contingent consideration paid	—			(3,969		)
Translation adjustment	(13		)	(106		)
Balance at end of year	$	1,909		$	2,656

The change in fair value of contingent consideration is included in acquisition related expenses, restructuring, integration and other charges in the Company’s Consolidated Statement of Income. In the fiscal year ended June 30, 2018, the Company recorded a net benefit of $2,281 primarily due to a decrease in the fair value of contingent consideration primarily related to Better Bean due to lower probability of achievement of specified operating results.

There were no transfers of financial instruments between the three levels of fair value hierarchy during the fiscal years ended June 30, 2018 or 2017.

The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s debt approximates fair value due to the debt bearing fluctuating market interest rates (See Note 11, Debt and Borrowings).

Derivative Instruments

The Company primarily has exposure to changes in foreign currency exchange rates relating to certain anticipated cash flows and firm commitments from its international operations. The Company may enter into certain derivative financial instruments, when available on a cost-effective basis, to manage such risk. Derivative financial instruments are not used for speculative purposes. The fair value of these derivatives is included in prepaid expenses and other current assets and accrued expenses and other current liabilities in the Consolidated Balance Sheet. For derivative instruments that qualify as hedges of probable forecasted cash flows, the effective portion of changes in fair value is temporarily reported in accumulated other comprehensive income and recognized in earnings when the hedged item affects earnings. Fair value hedges and derivative instruments not designated as hedges are marked-to-market each reporting period with any unrealized gains or losses recognized in earnings.

Derivative instruments designated at inception as hedges are measured for effectiveness at the inception of the hedge and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in off-setting changes in the cash flows of hedged items. Any ineffective portion of change in fair value is not deferred in accumulated other comprehensive income and is included in current period results. The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable of occurring on the originally forecasted date or when the hedge is no longer effective. There were no discontinued foreign exchange hedges for the fiscal years ended June 30, 2018 and June 30, 2017.

There were no cash flow hedges outstanding as of June 30, 2018. The notional and fair value amounts of cash flow hedges at June 30, 2017 were $1,828 and $84 of net assets, respectively. There were no fair value hedges outstanding as of June 30, 2018 and June 30, 2017.

The notional and fair value amounts of derivatives not designated as hedges at June 30, 2018 were $20,986 and $338 of net assets, respectively. There were $6,114 of notional amount and $38 of net liabilities of derivatives not designated as hedges as of June 30, 2017.

Gains and losses related to both designated and non-designated foreign currency exchange contracts are recorded in the Company’s consolidated statements of operations based upon the nature of the underlying hedged transaction and were not material in the fiscal years ended June 30, 2018 and 2017.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Commitments and Contingencies

12 Months Ended

Jun. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

Lease commitments and rent expense

The Company leases office, manufacturing and warehouse space. These leases provide for additional payments of real estate taxes and other operating expenses over a base period amount.

The aggregate minimum future lease payments for these operating leases at June 30, 2018 are as follows:



Fiscal Year
2019	$	16,382
2020	14,044
2021	10,566
2022	9,453
2023	8,848
Thereafter	44,360
	$	103,653

Rent expense charged to operations for the fiscal years ended June 30, 2018, 2017 and 2016 was $36,054, $35,153 and $32,444, respectively.

Off Balance Sheet Arrangements

At June 30, 2018, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K that have had, or are likely to have, a material current or future effect on our consolidated financial statements.

Legal Proceedings

Securities Class Actions Filed in Federal Court

On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The Hain Celestial Group, Inc., et al. (the “Flora Complaint”); (2) Lynn v. The Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). On June 5, 2017, the court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola voluntarily dismissed his claims without prejudice to his ability to participate in the Consolidated Securities Action as an absent class member. The Co-Lead Plaintiffs in the Consolidated Securities Action filed a Consolidated Amended Complaint on August 4, 2017 and a Corrected Consolidated Amended Complaint on September 7, 2017 on behalf of a purported class consisting of all persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the “Amended Complaint”). The Amended Complaint names as defendants the Company and certain of its current and former officers (collectively, the “Defendants”) and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss on October 3, 2017. Co-Lead Plaintiffs filed an opposition on December 1, 2017, and Defendants filed the reply on January 16, 2018. On April 4, 2018, the Court requested additional briefing relating to certain aspects of Defendants’ motion to dismiss. In accordance with this request, Lead Plaintiffs submitted their supplemental brief on April 18, 2018, and Defendants submitted an opposition on May 2, 2018. Lead Plaintiffs filed a reply brief on May 9, 2018, and Defendants submitted a sur-reply on May 16, 2018.

Stockholder Derivative Complaints Filed in State Court

On September 16, 2016, a stockholder derivative complaint, Paperny v. Heyer, et al. (the “Paperny Complaint”), was filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers of the Company alleging breach of fiduciary duty, unjust enrichment, lack of oversight and corporate waste. On December 2, 2016 and December 29, 2016, two additional stockholder derivative complaints were filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers under the captions Scarola v. Simon (the “Scarola Complaint”) and Shakir v. Simon (the “Shakir Complaint” and, together with the Paperny Complaint and the Scarola Complaint, the “Derivative Complaints”), respectively. Both the Scarola Complaint and the Shakir Complaint allege breach of fiduciary duty, lack of oversight and unjust enrichment. On February 16, 2017, the parties for the Derivative Complaints entered into a stipulation consolidating the matters under the caption In re The Hain Celestial Group (the “Consolidated Derivative Action”) in New York State Supreme Court in Nassau County, ordering the Shakir Complaint as the operative complaint. On November 2, 2017, the parties agreed to stay the Consolidated Derivative Action until April 11, 2018. On April 6, 2018, the parties filed a proposed stipulation agreeing to stay the Consolidated Derivative Action until October 4, 2018, which the Court granted on May 3, 2018.

Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court

On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District of New York against the Board of Directors and certain officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.

On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the Board of Directors and certain officers of the Company. The complaint alleges that the Company’s directors and certain officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleges that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August 9, 2017, the Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff (the “Merenstein Complaint”).

On August 10, 2017, the court granted the parties stipulation to consolidate the Barnes Complaint, the Silva Complaint and the Merenstein Complaint under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”) and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel, with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. On September 14, 2017, a related complaint was filed under the caption Oliver v. Berke, et al. (the “Oliver Complaint”), and on October 6, 2017, the Oliver Complaint was consolidated with the Consolidated Stockholder Class and Derivative Action. The Plaintiffs filed their consolidated amended complaint under seal on October 26, 2017. On December 20, 2017, the parties agreed to stay Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through and including 30 days after a decision is rendered on the motion to dismiss the Amended Complaint in the consolidated Securities Class Actions, described above.

Center for Environmental Health v. Save Mart Supermarkets, et.al., Superior Court of the State of California, Alameda County

On August 19, 2015, the Center for Environmental Health (“CEH”), a private enforcer, filed a complaint under the California Safe Drinking Water and Toxic Enforcement Act (the “Enforcement Act”) (commonly referred to as “Proposition 65”), naming various defendants, including the Company. The complaint alleges that the Company is required to provide warnings for certain of its products for alleged exposure to the substance listed under the Enforcement Act as “acrylamide.” The other defendants named in the action are five retailers and one distributor, all of which are named for the Company’s products at issue. Acrylamide is a chemical that can form in some foods during high-temperature cooking processes, such as frying, roasting, and baking. The complaint seeks injunctive relief, civil penalties in the amount of $2,500 per day (unrounded) for each alleged violation, and CEH’s attorneys’ fees and costs.

To date, the Company has answered the complaint, denying the allegations, and engaged in discovery, including fact discovery and expert discovery. The Court bifurcated the trial into two phases for liability and remedies respectively, and the first phase of the trial is expected to be limited to determining liability and the Company’s establishment of the “no significant risk level.”

The parties sought a continuance of the trial date to January 14, 2019 and a stay of the litigation through October 13, 2018 in order to pursue mediation. On August 27, 2018, the Court issued an order granting the parties’ stipulation and continuing the trial date to January 14, 2019 per the parties’ request.

SEC Investigation

As previously disclosed, the Company voluntarily contacted the SEC in August 2016 to advise it of the Company’s delay in the filing of its periodic reports and the performance of the independent review conducted by the Audit Committee. The Company has reached an agreement with the staff, subject to approval by the commission, that fully resolves this matter, without any finding of intentional wrongdoing and without any monetary penalty, while noting the Company’s ongoing cooperation. The settlement, if approved, relates to the Company’s previously disclosed material weakness in internal controls over financial reporting.

Other

In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial position, cash flows or liquidity.

Defined Contribution Plans	12 Months Ended
Defined Contribution Plans	Jun. 30, 2018
Retirement Benefits [Abstract]
Defined Contribution Plans	DEFINED CONTRIBUTION PLANS We have a 401(k) Employee Retirement Plan (the “Plan”) to provide retirement benefits for eligible employees. All full-time employees of the Company and its wholly-owned domestic subsidiaries are eligible to participate upon completion of 30 days of service. On an annual basis, we may, in our sole discretion, make certain matching contributions. For the fiscal years ended June 30, 2018, 2017 and 2016, we made contributions to the Plan of $1,371, $1,367 and $1,236, respectively, including with respect to employees of Hain Pure Protein. In addition, while certain of our international subsidiaries maintain separate defined contribution plans for their employees, the amounts are not significant to the Company’s consolidated financial statements.

Segment Information

12 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION

Prior to July 1, 2017, the Company’s operations were managed in eight operating segments: the United States, United Kingdom, Tilda, HPPC, Empire, Canada, Europe and Cultivate. The United States operating segment was also a reportable segment. The United Kingdom and Tilda operating segments were reported in the aggregate as “United Kingdom”, while HPPC and Empire were reported in the aggregate as “Hain Pure Protein,” and Canada, Europe and Cultivate were combined and reported as “Rest of World.”

Effective July 1, 2017, due to changes to the Company’s internal management and reporting structure, the United Kingdom operations of the Ella’s Kitchen®brand, which was previously included within the United States reportable segment, was moved to the United Kingdom reportable segment. Beginning in the third quarter ended March 31, 2018, the Hain Pure Protein operations were classified as discontinued operations as discussed in “Note 5, Discontinued Operations.” Therefore, segment information presented excludes the results of Hain Pure Protein. As a result, the Company is now managed in seven operating segments: the United States, United Kingdom, Tilda, Ella’s Kitchen UK, Europe, Canada and Cultivate.

The prior period segment information contained below has been adjusted to reflect the Company’s revised operating and reporting structure.

Net sales and operating income are the primary measures used by the Company’s Chief Operating Decision Maker (“CODM”) to evaluate segment operating performance and to decide how to allocate resources to segments. The CODM is the Company’s Chief Executive Officer. Expenses related to certain centralized administration functions that are not specifically related to an operating segment are included in “Corporate and Other.” Corporate and Other expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other selected employees who perform duties related to the entire enterprise, as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a whole. Additionally, acquisition related expenses, restructuring and integration charges, impairment charges and accounting review costs are included in “Corporate and Other.” Expenses that are managed centrally but can be attributed to a segment, such as employee benefits and certain facility costs, are allocated based on reasonable allocation methods. Assets are reviewed by the CODM on a consolidated basis and therefore are not reported by operating segment.

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.



	Fiscal Years Ended June 30,
	2018			2017			2016
Net Sales: ⁽¹⁾
United States	$	1,084,871		$	1,107,806		$	1,164,817
United Kingdom	938,029			851,757			859,183
Rest of World	434,869			383,942			368,864
	$	2,457,769		$	2,343,505		$	2,392,864

Operating Income:
United States	$	86,319		$	145,307		$	188,671
United Kingdom	56,046			51,948			70,809
Rest of World	38,660			32,010			27,898
	181,025			229,265			287,378
Corporate and Other ⁽²⁾	(74,985		)	(119,842		)	(168,577		)
	$	106,040		$	109,423		$	118,801

(1)

One of our customers accounted for approximately 11%, 12%, and 12% of our consolidated net sales for the fiscal years ended June 30, 2018, 2017 and 2016, respectively, which were primarily related to the United States and United Kingdom segments. A second customer accounted for approximately, 11%, 11% and 12% of our consolidated net sales for the fiscal years ended June 30, 2018, 2017 and 2016, respectively, which were primarily related to the United States segment.

(2)

For the fiscal year ended June 30, 2018, Corporate and Other included $12,841 of acquisition related expenses, restructuring, integration and other charges and $9,293 of accounting review and remediation costs, net of insurance proceeds. Corporate and Other for the fiscal year ended June 30, 2018 also included impairment charges of $5,632 ($5,100 related to Rest of World and $532 related to the United Kingdom segment) related to certain of the Company’s trade names. For the fiscal year ended June 30, 2017, Corporate and Other included $29,562 of accounting review and remediation costs, $10,388 of acquisition related expenses, restructuring, integration and other charges. Corporate and Other for the fiscal year ended June 30, 2017 also included impairment charges of $14,079 ($7,579 related to the United Kingdom segment and $6,500 related to the United States segment) related to certain of the Company’s trade names, a $26,373 impairment charge primarily related to long-lived assets associated with the exit of certain portions of our own-label chilled desserts business in the United Kingdom segment. For the fiscal year ended June 30, 2016, Corporate and Other included $12,065 of acquisition related expenses, restructuring, integration and other charges, goodwill impairment charges of $84,548 related to the United Kingdom segment, an impairment charge of $39,724 ($20,932 related to the United Kingdom segment and $18,792 related to the United States segment) related to certain of the Company’s trade names and a $3,476 impairment charge related to long-lived assets associated with the divestiture of certain portions of our own-label juice business in the United Kingdom.

The Company’s net sales by product category are as follows:



	Fiscal Year Ended June 30,
	2018		2017		2016
Grocery	$	1,842,535	$	1,743,860	$	1,800,640
Snacks	302,795		312,784		307,797
Personal Care	196,245		176,408		171,669
Tea	116,194		110,453		112,758
Total	$	2,457,769	$	2,343,505	$	2,392,864

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows:



	Fiscal Year Ended June 30,
	2018		2017		2016
United States	$	1,144,832	$	1,167,688	$	1,237,240
United Kingdom	938,029		851,757		859,183
All Other	374,908		324,060		296,441
Total	$	2,457,769	$	2,343,505	$	2,392,864

The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic region are as follows:



	Fiscal Year Ended June 30,
	2018		2017
United States	$	99,650	$	112,373
United Kingdom	174,214		165,334
All Other	86,700		63,392
Total	$	360,564	$	341,099

Quarterly Financial Data (Unaudited)

12 Months Ended

Jun. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Data (Unaudited)

QUARTERLY FINANCIAL DATA (UNAUDITED)

A summary of the Company’s consolidated quarterly results of operations is as follows. The sum of the net income per share from continuing operations for each of the four quarters may not equal the net income per share for the full year, as presented, due to rounding.



	Three Months Ended
	June 30, 2018			March 31, 2018			December 31, 2017		September 30, 2017
Net sales	$	619,598		$	632,720		$	616,232	$	589,219
Gross profit	$	125,097		$	133,013		$	133,950	$	123,388
Operating income	$	16,580		$	29,254		$	30,965	$	29,241
Income before income taxes and equity in earnings of equity-method investees	$	5,838		$	24,032		$	25,246	$	26,086
Net (loss) income from continuing operations	$	(4,556	)	$	25,241		$	43,130	$	18,613
Net (loss) income from discontinued operations, net of tax	$	(65,385	)	$	(12,555	)	$	3,973	$	1,233
Net (loss) income	$	(69,941	)	$	12,686		$	47,103	$	19,846

Net income (loss) per common share:
Basic net (loss) income per common share from continuing operations	$	(0.04	)	$	0.24		$	0.42	$	0.18
Basic net (loss) income per common share from discontinued operations	$	(0.63	)	$	(0.12	)	$	0.04	$	0.01
Basic net income (loss) per common share	$	(0.67	)	$	0.12		$	0.45	$	0.19

Diluted net (loss) income per common share from continuing operations	$	(0.04	)	$	0.24		$	0.41	$	0.18
Diluted net (loss) income per common share from discontinued operations	$	(0.63	)	$	(0.12	)	$	0.04	$	0.01
Diluted net income (loss) per common share	$	(0.67	)	$	0.12		$	0.45	$	0.19

The quarter ended June 30, 2018 was impacted by goodwill impairment charges of $7,700 ($5,553 net of tax) in the Cultivate operating segment, impairment charges of $5,632 ($5,192 net of tax) related to indefinite-lived intangible assets (trade names), as well as a $113 ($104 net of tax) impairment charge primarily related to the closure of manufacturing facilities in the United States. Additionally, the quarter ended June 30, 2018 was impacted by $2,887 ($1,941 net of tax) related to professional fees associated with our internal accounting review and remediation costs, net of insurance proceeds. Net loss from discontinued operations in the quarter ended June 30, 2018 was impacted by asset impairment charges of $78,464 to adjust the carrying value of Hain Pure Protein to its fair value, less its cost to sell.

The quarter ended March 31, 2018 was impacted by impairment charges of $2,557 ($2,050 net of tax) primarily related to the closure of a manufacturing facility of certain soup products in the United Kingdom, as well as an impairment charge of $2,057 ($1,648 net of tax) related to the discontinuation of additional slow moving SKUs in the United States as part of an ongoing product rationalization initiative. Additionally, the quarter ended March 30, 2018 was impacted by $3,313 ($2,654 net of tax) related to professional fees associated with our internal accounting review and remediation costs.

The quarter ended December 31, 2017 was impacted by impairment charges of $3,449 ($2,593 net of tax) related to the closure of a facility in the United States, as well as $4,451 ($3,346 net of tax) related to professional fees associated with our internal accounting review and remediation costs.

The quarter ended September 30, 2017 was impacted by $3,642 ($2,638 net of tax) related to professional fees associated with our internal accounting review and insurance proceeds of $5,000 ($3,622 net of tax) related to the reimbursement of costs incurred as part of the internal accounting review and the independent review by the Audit Committee and other related matters.



	Three Months Ended
	June 30, 2017			March 31, 2017			December 31, 2016		September 30, 2016
Net sales	$	602,891		$	588,798		$	587,021	$	564,795
Gross profit	$	143,862		$	139,203		$	130,011	$	106,320
Operating income	$	7,174		$	49,621		$	37,859	$	14,769
Income before income taxes and equity in earnings of equity-method investees	$	1,366		$	42,150		$	34,116	$	10,246
Net (loss) income from continuing operations	$	(1,504	)	$	32,824		$	24,769	$	9,452
Net income (loss) from discontinued operations, net of tax	$	1,817		$	(1,496	)	$	2,417	$	(849	)
Net income	$	313		$	31,328		$	27,185	$	8,604

Net income (loss) per common share:
Basic net (loss) income per common share from continuing operations	$	(0.01	)	$	0.32		$	0.24	$	0.09
Basic net income (loss) per common share from discontinued operations	$	0.02		$	(0.01	)	$	0.02	$	(0.01	)
Basic net income per common share	$	—		$	0.30		$	0.26	$	0.08

Diluted net (loss) income per common share from continuing operations	$	(0.01	)	$	0.31		$	0.24	$	0.09
Diluted net income (loss) per common share from discontinued operations	$	0.02		$	(0.01	)	$	0.02	$	(0.01	)
Diluted net income per common share	$	—		$	0.30		$	0.26	$	0.08

The quarter ended June 30, 2017 was impacted by impairment charges of $14,079 ($10,733 net of tax) related to indefinite-lived intangible assets (trade names), as well as a $26,373 ($20,877 net of tax) impairment charge primarily related to long-lived assets associated with the exit of certain portions of our own-label chilled desserts business in the United Kingdom. Additionally, the quarter ended June 30, 2017 was impacted by $9,473 ($6,773 net of tax) related to professional fees associated with our internal accounting review.

The quarters ended March 31, 2017, December 31, 2016 and September 30, 2016 were impacted by $7,124 ($5,029 net of tax), $7,005 ($5,050 net of tax) and $5,960 ($4,112 net of tax), respectively, related to professional fees associated with our internal accounting review.

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Jun. 30, 2018

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation and Qualifying Accounts

The Hain Celestial Group, Inc. and Subsidiaries

Schedule II - Valuation and Qualifying Accounts



Column A	Column B		Column C				Column D			Column E
			Additions
	Balance at beginning of period		Charged to costs and expenses		Charged to other accounts - describe (i)		Deductions - describe (ii)			Balance at end of period
Fiscal Year Ended June 30, 2018:
Allowance for doubtful accounts	$	1,447	$	1,880	$	49	$	(1,290	)	$	2,086
Valuation allowance for deferred tax assets	$	14,850	$	1,251	$	—	$	(1,132	)	$	14,969

Fiscal Year Ended June 30, 2017:
Allowance for doubtful accounts	$	936	$	1,077	$	149	$	(715	)	$	1,447
Valuation allowance for deferred tax assets	$	15,310	$	1,862	$	—	$	(2,322	)	$	14,850

Fiscal Year Ended June 30, 2016:
Allowance for doubtful accounts	$	896	$	208	$	54	$	(222	)	$	936
Valuation allowance for deferred tax assets	$	10,926	$	7,484	$	—	$	(3,100	)	$	15,310
Amounts above are inclusive our Hain Pure Protein reporting segment classified as discontinued operations


(i)	Represents the allowance for doubtful accounts of the business acquired during the fiscal year


(ii)	Amounts written off and changes in exchange rates

Summary of Significant Accounting Policies and Practices (Policies)

12 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Segment Reporting

Changes in Segments

Effective July 1, 2017, due to changes to the Company’s internal management and reporting structure, the United Kingdom operations of the Ella’s Kitchen^® brand (“Ella’s Kitchen UK”), which was previously included within the United States reportable segment, became a separate operating segment and was aggregated within the United Kingdom reportable segment. See Note 19, Segment Information, for additional information on the Company’s operating and reportable segments.

Basis of Presentation

The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net income includes the Company’s equity in the current earnings or losses of such companies.

Unless otherwise indicated, references in these consolidated financial statements to 2018, 2017 and 2016 or “fiscal” 2018, 2017 and 2016 or other years refer to our fiscal year ended June 30 of that respective year and references to 2019 or “fiscal” 2019 refer to our fiscal year ending June 30, 2019.

Reclassifications

Certain prior year amounts have been reclassified to conform with current year presentation.

Use of Estimates

The financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. These estimates include, among others, revenue recognition, trade promotions and sales incentives, valuation of accounts and chargeback receivables, accounting for acquisitions, valuation of long-lived assets, goodwill and intangible assets, stock-based compensation, and valuation allowances for deferred tax assets. We believe in the quality and reasonableness of our critical accounting estimates; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have consistently applied.

Cash and Cash Equivalents

Revenue

Revenue Recognition

Trade Promotions and Sales Incentives

Valuation of Accounts and Chargebacks Receivable and Concentration of Credit Risk

Inventory

Property, Plant and Equipment

Goodwill and Other Indefinite-Lived Intangible Assets

See Note 9, Goodwill and Other Intangible Assets for information on goodwill and intangibles impairment charges.

Cost of Sales

Foreign Currency Translation and Remeasurement

Selling, General and Administrative Expenses

Research and Development Costs

Advertising Costs

Income Taxes

Fair Value of Financial Instruments


•	Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;


•	Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and


•	Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

Derivative Instruments

Stock-Based Compensation

The Company has employee and director stock-based compensation plans.

Valuation of Long-Lived Assets

See Note 8, Property, Plant and Equipment, Net, and Note 5, Discontinued Operations, for information on long-lived asset impairment charges.

Net Income Per Share

Newly Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Effective

Newly Adopted Accounting Pronouncements


•	As required, we prospectively recognized a tax benefit of $309 in the income tax line item of our consolidated income statement for the fiscal year ended June 30, 2018 related to excess tax benefits upon vesting or settlement in that period.


•	We elected to adopt the cash flow presentation of the excess tax benefits retrospectively. As a result, we decreased our cash used in financing activities by $3,298 and $11,317 for the fiscal years ended June 30, 2017 and 2016, respectively.


•	We have elected to continue to estimate the number of stock-based awards expected to vest, rather than electing to account for forfeitures as they occur to determine the amount of compensation costs to be recognized in each period.


•	We have not changed our policy on statutory withholding requirements and will continue to allow an employee to withhold at the minimum statutory withholding requirements. Amounts paid by us to taxing authorities when directly withholding shares associated with employees’ income tax withholding obligations are classified as a financing activity in our cash flow statement.


•	We excluded the excess tax benefits from the assumed proceeds available to repurchase shares in the computation of our diluted earnings per share for the fiscal year ended June 30, 2018.


•	We did not have any material excess tax benefits previously recognized in additional paid-in capital; therefore, it was not necessary to record a deferred tax asset for the unrecognized tax benefits with an adjustment to opening retained earnings.

Recently Issued Accounting Pronouncements Not Yet Effective

The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-16.

Summary of Significant Accounting Policies and Practices (Tables)

12 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Summary of Property, Plant, and Equipment Useful Lives

The Company utilizes the following ranges of asset lives:



Buildings and improvements		10 - 40 years
Machinery and equipment		3 - 20 years
Furniture and fixtures		3 - 15 years

Property, plant and equipment, net consisted of the following:



	June 30, 2018		June 30, 2017
Land	$	28,378	$	28,092
Buildings and improvements	83,289		83,648
Machinery and equipment	323,348		300,750
Computer hardware and software	54,092		50,773
Furniture and fixtures	17,894		15,613
Leasehold improvements	31,519		29,296
Construction in progress	17,280		11,134
	555,800		519,306
Less: Accumulated depreciation	245,628		227,440
	$	310,172	$	291,866

Earnings Per Share (Tables)

12 Months Ended

Jun. 30, 2018

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:



	Fiscal Year Ended June 30,
	2018			2017		2016
Numerator:
Net income from continuing operations	$	82,428		$	65,541	$	27,571
Net (loss) income from discontinued operations, net of tax	$	(72,734	)	$	1,889	$	19,858
Net income	$	9,694		$	67,430	$	47,429

Denominator:
Basic weighted average shares outstanding	103,848			103,611		103,135
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	629			637		1,048
Diluted weighted average shares outstanding	104,477			104,248		104,183

Basic net income (loss) per common share:
Continuing operations	$	0.79		$	0.63	$	0.27
Discontinued operations	(0.70		)	0.02		0.19
Basic net income per common share	$	0.09		$	0.65	$	0.46

Diluted net income (loss) per common share:
Continuing operations	$	0.79		$	0.63	$	0.26
Discontinued operations	(0.70		)	0.02		0.19
Diluted net income per common share	$	0.09		$	0.65	$	0.46

Discontinued Operations (Tables)

12 Months Ended

Jun. 30, 2018

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Discontinued Operations



	Fiscal Year Ended June 30,
	2018			2017			2016
Net sales	$	509,475		$	509,606		$	492,510
Cost of sales	486,023			487,631			443,842
Gross profit	23,452			21,975			48,668
Asset impairments	78,464			—			—
Selling, general and administrative expense	18,743			19,180			15,740
Other expense	4,699			1,530			1,590
Net (loss) income from discontinued operations before income taxes	(78,454		)	1,265			31,338
(Benefit) provision for income taxes	(5,720		)	(624		)	11,480
Net (loss) income from discontinued operations, net of tax	$	(72,734	)	$	1,889		$	19,858

Assets and liabilities of discontinued operations presented in the Consolidated Balance Sheets as of June 30, 2018 and June 30, 2017 are included in the following table:




Assets	June 30, 2018			June 30, 2017
Cash and cash equivalents	$	6,461		$	9,937
Accounts receivable, less allowance for doubtful accounts	21,616			22,671
Inventories	105,359			85,313
Prepaid expenses and other current assets	5,604			5,866
Total current assets*				123,787
Property, plant and equipment, net	83,776			78,645
Goodwill	41,089			41,089
Trademarks and other intangible assets, net	51,029			52,040
Other assets	4,381			3,330
Total noncurrent assets of discontinued operations*				175,104
Impairments of long-lived assets held for sale	(78,464		)	—
Total assets of discontinued operations	$	240,851		$	298,891

Liabilities
Accounts payable	$	31,762		$	35,943
Accrued expenses and other current liabilities	6,880			2,005
Total current liabilities of discontinued operations*				37,948
Deferred tax liabilities	11,111			23,129
Other noncurrent liabilities	93			193
Total noncurrent liabilities of discontinued operations*				23,322
Total liabilities of discontinued operations	$	49,846		$	61,270

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760

+ Details

Acquisitions (Tables)

12 Months Ended

Jun. 30, 2018

Business Combinations [Abstract]

Summary of Unaudited Pro Forma Results of Continuing Operations



	Fiscal Year Ended
	June 30, 2016
Net sales from continuing operations	$	2,481,362
Net income from continuing operations	$	31,412
Net income per common share from continuing operations - diluted	$	0.30

Inventories (Tables)

12 Months Ended

Jun. 30, 2018

Inventory, Net [Abstract]

Components of Inventories

Inventories consisted of the following:



	June 30, 2018		June 30, 2017
Finished goods	$	231,926	$	214,547
Raw materials, work-in-progress and packaging	159,599		127,448
	$	391,525	$	341,995

Property, Plant and Equipment, Net (Tables)

12 Months Ended

Jun. 30, 2018

Property, Plant and Equipment [Abstract]

Summary of Property, Plant, and Equipment, Net

The Company utilizes the following ranges of asset lives:



Buildings and improvements		10 - 40 years
Machinery and equipment		3 - 20 years
Furniture and fixtures		3 - 15 years

Property, plant and equipment, net consisted of the following:



	June 30, 2018		June 30, 2017
Land	$	28,378	$	28,092
Buildings and improvements	83,289		83,648
Machinery and equipment	323,348		300,750
Computer hardware and software	54,092		50,773
Furniture and fixtures	17,894		15,613
Leasehold improvements	31,519		29,296
Construction in progress	17,280		11,134
	555,800		519,306
Less: Accumulated depreciation	245,628		227,440
	$	310,172	$	291,866

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Jun. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in Carrying Amount of Goodwill

The following table shows the changes in the carrying amount of goodwill by business segment:



	United States			United Kingdom			Rest of World			Total
Balance as of June 30, 2016 (a)	$	605,702		$	332,561		$	80,984		$	1,019,247
Acquisition activity	—			6,962			3,083			10,045
Reallocation of goodwill between reporting units (b)	(16,377		)	—			16,377			—
Translation and other adjustments, net	(992		)	(10,388		)	980			(10,400		)
Balance as of June 30, 2017 (a)	588,333			329,135			101,424			1,018,892
Acquisition activity	—			7,062			—			7,062
Reallocation of goodwill between reporting units (c)	(35,519		)	35,519			—			—
Impairment charge	—			—			(7,700		)	(7,700		)
Translation and other adjustments, net	—			5,447			435			5,882
Balance as of June 30, 2018 (d)	$	552,814		$	377,163		$	94,159		$	1,024,136

Components of Other Intangible Assets

The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization:



	June 30, 2018			June 30, 2017
Non-amortized intangible assets:
Trademarks and trade names (a)	$	385,609		$	384,917
Amortized intangible assets:
Other intangibles	239,323			232,112
Less: accumulated amortization	(114,545		)	(95,801		)
Net carrying amount	$	510,387		$	521,228

(a) The gross carrying value of trademarks and trade names is reflected net of $65,834 and $60,202 of accumulated impairment charges for the fiscal years ended June 30, 2018 and 2017, respectively.

Summary of Amortization Expense

Amortization expense included in continuing operations was as follows:



	Fiscal Year Ended June 30,
	2018		2017		2016
Amortization of intangible assets	$	18,202	$	16,988	$	17,544

Summary of Expected Amortization Expense Over the Next Five Years

Expected amortization expense over the next five fiscal years is as follows:



	Fiscal Year Ending June 30,
	2019		2020		2021		2022		2023
Estimated amortization expense	$	15,675	$	14,379	$	13,913	$	13,209	$	12,620

Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Jun. 30, 2018

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:



	June 30, 2018		June 30, 2017
Payroll, employee benefits and other administrative accruals	$	75,918	$	68,658
Facility, freight and warehousing accruals	20,970		20,019
Selling and marketing related accruals	15,546		9,734
Other accruals	3,567		8,316
	$	116,001	$	106,727

Debt and Borrowings Debt and Borrowings (Tables)

12 Months Ended

Jun. 30, 2018

Debt Disclosure [Abstract]

Summary of Debt and Borrowings

Debt and borrowings consisted of the following:



	June 30, 2018			June 30, 2017
Unsecured revolving credit facility	$	401,852		$	733,715
Term loan	296,250			—
Less: Unamortized issuance costs	(692		)	—
Tilda short-term borrowing arrangements	9,338			7,761
Other borrowings	7,358			8,285
	714,106			749,761
Short-term borrowings and current portion of long-term debt	26,605			9,626
Long-term debt, less current portion	$	687,501		$	740,135

Summary of Maturities of Debt Instruments

Maturities of all debt instruments at June 30, 2018, are as follows:



Due in Fiscal Year	Amount
2019	$	26,605
2020	16,988
2021	16,857
2022	15,339
2023	638,154
Thereafter	163
	$	714,106

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Income Taxes (Tables)

12 Months Ended

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Summary of Components of Income Before Taxes and Equity in Earnings of Equity-Method Investments

The components of income (loss) before income taxes and equity in earnings of equity-method investees were as follows:



	Fiscal Year Ended June 30,
	2018			2017		2016
Domestic	$	(13,936	)	$	47,781	$	126,686
Foreign	95,138			40,097		(39,617		)
Total	$	81,202		$	87,878	$	87,069

Summary of the Provision for Income Taxes

The provision (benefit) for income taxes consisted of the following:



	Fiscal Year Ended June 30,
	2018			2017			2016
Current:
Federal	$	(1,309	)	$	18,331		$	9,953
State and local	1,383			(293		)	1,668
Foreign	20,542			14,884			14,737
	20,616			32,922			26,358
Deferred:
Federal	(22,612		)	(3,198		)	30,711
State and local	1,973			960			5,017
Foreign	(864		)	(8,218		)	(2,635		)
	(21,503		)	(10,456		)	33,093
Total	$	(887	)	$	22,466		$	59,451

Reconciliation of Expected Income Taxes to Actual

The reconciliation of the U.S. federal statutory rate to our effective rate on income before provision for income taxes was as follows:



	Fiscal Year Ended June 30,
	2018			%		2017			%		2016			%
Expected United States federal income tax at statutory rate	$	22,818		28.1	%	$	30,757		35.0	%	$	30,474		35.0	%
State income taxes, net of federal benefit	2,774			3.4	%	2,757			3.1	%	4,263			4.9	%
Domestic manufacturing deduction	—			—	%	(846		)	(1.0	)%	(505		)	(0.6	)%
Foreign income at different rates	(7,174		)	(8.8	)%	(6,539		)	(7.4	)%	(4,051		)	(4.7	)%
Impairment of goodwill and intangibles	1,816			2.2	%	—			—	%	23,172			26.6	%
Change in valuation allowance	119			0.1	%	(60		)	(0.1	)%	5,067			5.8	%
Corporate tax reorganization	—			—	%	—			—	%	(4,173		)	(4.8	)%
Unrealized foreign exchange losses	—			—	%	807			0.9	%	7,056			8.1	%
Change in reserves for uncertain tax positions	(3,859		)	(4.8	)%	(4,417		)	(5.0	)%	1,448			1.7	%
Tax Act’s transition tax (b)	7,054			8.7	%	—			—	%	—			—	%
Tax Act’s impact of deferred taxes (a)	(25,006		)	(30.8	)%	—			—	%	—			—	%
Reduction of deferred tax liabilities resulting from change in United Kingdom tax rate	—			—	%	(1,841		)	(2.1	)%	(4,942		)	(5.7	)%
Other	571			0.8	%	1,848			2.2	%	1,642			2.0	%
(Benefit) provision for income taxes	$	(887	)	(1.1	)%	$	22,466		25.6	%	$	59,451		68.3	%

Schedule of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities consisted of the following:



	June 30, 2018			June 30, 2017
Noncurrent deferred tax assets/(liabilities):
Basis difference on inventory	$	9,139		$	9,003
Reserves not currently deductible	11,060			23,111
Basis difference on intangible assets	(97,365		)	(124,756		)
Basis difference on property and equipment	(8,444		)	(12,086		)
Other comprehensive income	(133		)	(768		)
Net operating loss and tax credit carryforwards	12,414			19,049
Stock-based compensation	1,348			3,996
Other	41			(616		)
Valuation allowances	(14,969		)	(14,850		)
Noncurrent deferred tax liabilities, net (1)	$	(86,909	)	$	(97,917	)


(1)	The June 30, 2017 the Consolidated Balance Sheet includes $429 of non-current deferred tax assets in Other Assets.

Summary of Changes in Valuation Allowances

The changes in valuation allowances against deferred income tax assets were as follows:



	Fiscal Year Ended June 30,
	2018			2017
Balance at beginning of year	$	14,850		$	15,310
Additions charged to income tax expense	1,251			1,862
Reductions credited to income tax expense	(1,345		)	(1,922		)
Currency translation adjustments	213			(400		)
Balance at end of year	$	14,969		$	14,850

Schedule of Unrecognized Tax Benefits, Including Interest and Penalties Activity

Unrecognized tax benefits activity, including interest and penalties, is summarized below:



	Fiscal Year Ended June 30,
	2018			2017			2016
Balance at beginning of year	$	11,602		$	16,019		$	10,759
Additions based on tax positions related to the current year	118			217			4,276
Additions based on tax positions related to prior years	—			—			1,404
Reductions due to lapse in statute of limitations and settlements	(4,990		)	(4,634		)	(420		)
Balance at end of year	$	6,730		$	11,602		$	16,019

Stockholders' Equity (Tables)

12 Months Ended

Jun. 30, 2018

Equity [Abstract]

Summary of Changes in Accumulated Other Comprehensive Income (Loss)

The following table present the changes in accumulated other comprehensive income (loss):



	Fiscal Year Ended June 30,
	2018			2017
Foreign currency translation adjustments:
Other comprehensive loss before reclassifications ⁽¹⁾	$	11,497		$	(22,951	)
Deferred gains/(losses) on cash flow hedging instruments:
Other comprehensive income before reclassifications	39			196
Amounts reclassified into income ⁽²⁾	(106		)	(575		)
Unrealized gain on available for sale investment:
Other comprehensive loss before reclassifications	(191		)	(51		)
Amounts reclassified into income ⁽³⁾	—			13
Net change in accumulated other comprehensive income (loss)	$	11,239		$	(23,368	)


(1)	Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were a gain of $493 and a loss of $18,385 for the fiscal years ended June 30, 2018 and 2017, respectively.


(2)	Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $132 and $1,233 for the fiscal years ended June 30, 2018 and 2017, respectively.

(3)

Stock-Based Compensation and Incentive Performance Plans (Tables)

12 Months Ended

Jun. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Compensation Cost and Related Income Tax Benefits Recognized

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock-based compensation plans were as follows:



	Fiscal Year Ended June 30,
	2018		2017		2016
Compensation cost (included in selling, general and administrative expense)	$	11,177	$	9,658	$	12,688
Related income tax benefit	$	2,165	$	3,622	$	4,758

Summary of Stock Option Activity

A summary of the stock option activity for the three fiscal years ended June 30 is as follows:



	2018	Weighted Average Exercise Price		2017		Weighted Average Exercise Price		2016		Weighted Average Exercise Price
Outstanding at beginning of year	122	$	2.26	342		$	6.66	1,249		$	6.12
Exercised	—	$	—	(220	)	$	9.10	(907	)	$	5.91
Outstanding at end of year	122	$	2.26	122		$	2.26	342		$	6.66

Options exercisable at end of year	122	$	2.26	122		$	2.26	342		$	6.66



	Fiscal Year Ended June 30,
	2018		2017		2016
Intrinsic value of options exercised	$	—	$	6,507	$	27,147
Cash received from stock option exercises	$	—	$	—	$	—
Tax benefit recognized from stock option exercises	$	—	$	2,538	$	10,587

Non-Vested Restricted Stock and Restricted Share Unit Awards

A summary of the restricted stock and restricted share units activity for the three fiscal years ended June 30 is as follows:



	2018		Weighted Average Grant Date Fair Value (per share)	2017		Weighted Average Grant Date Fair Value (per share)	2016		Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock and restricted share units - beginning of year	992		$27.59	1,121		$28.24	1,145		$32.30
Granted	685		$26.13	195		$33.68	416		$24.54
Vested	(433	)	$36.68	(290	)	$33.89	(408	)	$35.13
Forfeited	(187	)	$31.15	(34	)	$29.88	(32	)	$45.83
Non-vested restricted stock and restricted share units - end of year	1,057		$22.29	992		$27.59	1,121		$28.24

Restricted Stock Grant Information



	Fiscal Year Ended June 30,
	2018		2017		2016
Fair value of restricted stock and restricted share units granted	$	17,898	$	6,567	$	10,203
Fair value of shares vested	$	15,736	$	9,866	$	18,917
Tax benefit recognized from restricted shares vesting	$	5,235	$	3,768	$	7,139

Financial Instruments Measured at Fair Value (Tables)

12 Months Ended

Jun. 30, 2018

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2018:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	99	$	99	$	—	$	—
Forward foreign currency contracts	365		—		365		—
Available for sale securities	692		692		—		—
	$	1,156	$	791	$	365	$	—
Liabilities:
Forward foreign currency contracts	$	27	$	—	$	27	$	—
Contingent consideration, noncurrent	1,909		—		—		1,909
Total	$	1,936	$	—	$	27	$	1,909

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2017:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	21,800	$	21,800	$	—	$	—
Forward foreign currency contracts	99		—		99		—
Available for sale securities	882		882		—		—
	$	22,781	$	22,682	$	99	$	—
Liabilities:
Forward foreign currency contracts	53		—		53		—
Contingent consideration, current	2,656		—		—		2,656
Total	$	2,709	$	—	$	53	$	2,656

Summary of Level 3 Activity

The following table summarizes the Level 3 activity:



	Fiscal Year Ended June 30,
	2018			2017
Balance at beginning of year	$	2,656		$	3,553
Fair value of initial contingent consideration	1,547			2,652
Contingent consideration adjustment	(2,281		)	526
Contingent consideration paid	—			(3,969		)
Translation adjustment	(13		)	(106		)
Balance at end of year	$	1,909		$	2,656

Commitments and Contingencies (Tables)

12 Months Ended

Jun. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Summary of Minimum Future Lease Payments

The aggregate minimum future lease payments for these operating leases at June 30, 2018 are as follows:



Fiscal Year
2019	$	16,382
2020	14,044
2021	10,566
2022	9,453
2023	8,848
Thereafter	44,360
	$	103,653

Segment Information (Tables)

12 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.



	Fiscal Years Ended June 30,
	2018			2017			2016
Net Sales: ⁽¹⁾
United States	$	1,084,871		$	1,107,806		$	1,164,817
United Kingdom	938,029			851,757			859,183
Rest of World	434,869			383,942			368,864
	$	2,457,769		$	2,343,505		$	2,392,864

Operating Income:
United States	$	86,319		$	145,307		$	188,671
United Kingdom	56,046			51,948			70,809
Rest of World	38,660			32,010			27,898
	181,025			229,265			287,378
Corporate and Other ⁽²⁾	(74,985		)	(119,842		)	(168,577		)
	$	106,040		$	109,423		$	118,801

(1)

(2)

Summary of Revenue by Product Category

The Company’s net sales by product category are as follows:



	Fiscal Year Ended June 30,
	2018		2017		2016
Grocery	$	1,842,535	$	1,743,860	$	1,800,640
Snacks	302,795		312,784		307,797
Personal Care	196,245		176,408		171,669
Tea	116,194		110,453		112,758
Total	$	2,457,769	$	2,343,505	$	2,392,864

Summary of Net Sales by Geographic Areas

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows:



	Fiscal Year Ended June 30,
	2018		2017		2016
United States	$	1,144,832	$	1,167,688	$	1,237,240
United Kingdom	938,029		851,757		859,183
All Other	374,908		324,060		296,441
Total	$	2,457,769	$	2,343,505	$	2,392,864

Schedule of Long Lived Assets, by Geographic Region

The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic region are as follows:



	Fiscal Year Ended June 30,
	2018		2017
United States	$	99,650	$	112,373
United Kingdom	174,214		165,334
All Other	86,700		63,392
Total	$	360,564	$	341,099

Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Jun. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Data



	Three Months Ended
	June 30, 2018			March 31, 2018			December 31, 2017		September 30, 2017
Net sales	$	619,598		$	632,720		$	616,232	$	589,219
Gross profit	$	125,097		$	133,013		$	133,950	$	123,388
Operating income	$	16,580		$	29,254		$	30,965	$	29,241
Income before income taxes and equity in earnings of equity-method investees	$	5,838		$	24,032		$	25,246	$	26,086
Net (loss) income from continuing operations	$	(4,556	)	$	25,241		$	43,130	$	18,613
Net (loss) income from discontinued operations, net of tax	$	(65,385	)	$	(12,555	)	$	3,973	$	1,233
Net (loss) income	$	(69,941	)	$	12,686		$	47,103	$	19,846

Net income (loss) per common share:
Basic net (loss) income per common share from continuing operations	$	(0.04	)	$	0.24		$	0.42	$	0.18
Basic net (loss) income per common share from discontinued operations	$	(0.63	)	$	(0.12	)	$	0.04	$	0.01
Basic net income (loss) per common share	$	(0.67	)	$	0.12		$	0.45	$	0.19

Diluted net (loss) income per common share from continuing operations	$	(0.04	)	$	0.24		$	0.41	$	0.18
Diluted net (loss) income per common share from discontinued operations	$	(0.63	)	$	(0.12	)	$	0.04	$	0.01
Diluted net income (loss) per common share	$	(0.67	)	$	0.12		$	0.45	$	0.19



	Three Months Ended
	June 30, 2017			March 31, 2017			December 31, 2016		September 30, 2016
Net sales	$	602,891		$	588,798		$	587,021	$	564,795
Gross profit	$	143,862		$	139,203		$	130,011	$	106,320
Operating income	$	7,174		$	49,621		$	37,859	$	14,769
Income before income taxes and equity in earnings of equity-method investees	$	1,366		$	42,150		$	34,116	$	10,246
Net (loss) income from continuing operations	$	(1,504	)	$	32,824		$	24,769	$	9,452
Net income (loss) from discontinued operations, net of tax	$	1,817		$	(1,496	)	$	2,417	$	(849	)
Net income	$	313		$	31,328		$	27,185	$	8,604

Net income (loss) per common share:
Basic net (loss) income per common share from continuing operations	$	(0.01	)	$	0.32		$	0.24	$	0.09
Basic net income (loss) per common share from discontinued operations	$	0.02		$	(0.01	)	$	0.02	$	(0.01	)
Basic net income per common share	$	—		$	0.30		$	0.26	$	0.08

Diluted net (loss) income per common share from continuing operations	$	(0.01	)	$	0.31		$	0.24	$	0.09
Diluted net income (loss) per common share from discontinued operations	$	0.02		$	(0.01	)	$	0.02	$	(0.01	)
Diluted net income per common share	$	—		$	0.30		$	0.26	$	0.08

Description of Business and Basis of Presentation (Details) $ in Millions	12 Months Ended
	Jun. 30, 2020 USD ($)	Jun. 30, 2018 country unit
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which company operates (more than) \| country		80
Machinery and equipment
Property, Plant and Equipment [Line Items]
Number of SKUs		400
Number of SKUs identified to date		1,100
Machinery and equipment \| Forecast
Property, Plant and Equipment [Line Items]
Estimated savings \| $	$ 350

Summary of Significant Accounting Policies and Practices (Valuation of Accounts and Chargebacks Receivable and Concentration of Credit Risk) (Details) - Customer Concentration Risk	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Trade Receivable
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	12.00%
Sales \| First Customer
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	12.00%	12.00%
Sales \| Second Customer
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	11.00%	12.00%

Summary of Significant Accounting Policies and Practices (PPE Useful Life) (Details)	12 Months Ended
	Jun. 30, 2018
Minimum \| Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	10 years
Minimum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	3 years
Minimum \| Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	3 years
Minimum \| Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	3 years
Maximum \| Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	40 years
Maximum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	20 years
Maximum \| Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	15 years
Maximum \| Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	15 years

Summary of Significant Accounting Policies and Practices (Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
	Oct. 25, 2014	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Accounting Policies [Abstract]
Research and development costs		$ 9,696	$ 10,130	$ 11,354
Advertising costs		35,138	30,333	24,835
Money market securities, fair value		99	21,800
Business Interruption Loss [Line Items]
Gain on fire insurance recovery		$ 0	$ 0	$ 9,752
Tilda Milling Facility Fire
Business Interruption Loss [Line Items]
Gain on fire insurance recovery	$ 9,752

Summary of Significant Accounting Policies and Practices (Newly Adopted Accounting Pronouncements) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Discrete tax expense (benefit)	$ 309
Decrease in financing activities	$ 69,482	$ 147,089	$ 3,212
ASU 2016-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in financing activities		$ (3,298)	$ (11,317)

Chief Executive Officer Succession Plan (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands			3 Months Ended		6 Months Ended	12 Months Ended
	Jun. 25, 2018	Sep. 26, 2017	Jun. 30, 2018	Sep. 30, 2017	Dec. 31, 2018	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued in the period (in shares)						685	195	416
Fair value (USD per share)						$ 26.13	$ 33.68	$ 24.54
Stock-based compensation expense						$ 11,177	$ 9,658	$ 12,688
CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash separation payment						1,453
Continuation costs	$ 209
Stock-based compensation expense						(2,244)
Reduction to stock-based compensation expense						2,222
Additional stock-based compensation expense						19
CEO \| Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash separation payment					$ 34,294
Additional stock-based compensation expense					445
CEO \| TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued in the period (in shares)		164	164	164
Fair value (USD per share)	$ 3.19	$ 31.60	$ 3.19	$ 31.60
Stock-based compensation expense						$ 22
CEO \| TSR \| Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expense from grant					$ 524

Earnings Per Share (Computation of Basic and Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Earnings Per Share [Abstract]
Net income from continuing operations	$ (4,556)	$ 25,241	$ 43,130	$ 18,613	$ (1,504)	$ 32,824	$ 24,769	$ 9,452	$ 82,428	$ 65,541	$ 27,571
Net (loss) income from discontinued operations, net of tax	(65,385)	(12,555)	3,973	1,233	1,817	(1,496)	2,417	(849)	(72,734)	1,889	19,858
Net income	$ (69,941)	$ 12,686	$ 47,103	$ 19,846	$ 313	$ 31,328	$ 27,185	$ 8,604	$ 9,694	$ 67,430	$ 47,429
Denominator:
Basic weighted average shares outstanding (shares)									103,848	103,611	103,135
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units (shares)									629	637	1,048
Diluted weighted average shares outstanding (shares)									104,477	104,248	104,183
Basic net income (loss) per common share:
Basic net income per common share from continuing operations (USD per share)	$ (0.04)	$ 0.24	$ 0.42	$ 0.18	$ (0.01)	$ 0.32	$ 0.24	$ 0.09	$ 0.79	$ 0.63	$ 0.27
Basic net income (loss) per common share from discontinued operations (USD per share)	(0.63)	(0.12)	0.04	0.01	0.02	(0.01)	0.02	(0.01)	(0.70)	0.02	0.19
Basic net income per common share (USD per share)	(0.67)	0.12	0.45	0.19	0.00	0.30	0.26	0.08	0.09	0.65	0.46
Diluted net income (loss) per common share:
Diluted net income per common share from continuing operations (USD per share)	(0.04)	0.24	0.41	0.18	(0.01)	0.31	0.24	0.09	0.79	0.63	0.26
Diluted net income (loss) per common share from discontinued operations (USD per share)	(0.63)	(0.12)	0.04	0.01	0.02	(0.01)	0.02	(0.01)	(0.70)	0.02	0.19
Diluted net income per common share (USD per share)	$ (0.67)	$ 0.12	$ 0.45	$ 0.19	$ 0.00	$ 0.30	$ 0.26	$ 0.08	$ 0.09	$ 0.65	$ 0.46

Earnings Per Share (Narrative) (Details) - USD ($)	12 Months Ended
Earnings Per Share (Narrative) (Details) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Jun. 21, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Authorized amount				$ 250,000,000
Remaining authorized repurchase amount	$ 250,000,000
Stock-Based Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	560,000	271,000	282,000
Restricted Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	4,000	12,000	0

Discontinued Operations (Narrative) (Details) - Hain Pure Protein - Held for Sale - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairments of long-lived assets held for sale	$ 78,464	$ 0
Deferred income tax benefit	20,166
Deferred tax liability	$ 12,250

Discontinued Operations (Statements of Operations) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net (loss) income from discontinued operations, net of tax	$ (65,385)	$ (12,555)	$ 3,973	$ 1,233	$ 1,817	$ (1,496)	$ 2,417	$ (849)	$ (72,734)	$ 1,889	$ 19,858
Hain Pure Protein \| Held for Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales									509,475	509,606	492,510
Cost of sales									486,023	487,631	443,842
Gross profit									23,452	21,975	48,668
Asset impairments									78,464	0	0
Selling, general and administrative expense									18,743	19,180	15,740
Other expense									4,699	1,530	1,590
Net (loss) income from discontinued operations before income taxes									(78,454)	1,265	31,338
(Benefit) provision for income taxes									(5,720)	(624)	11,480
Net (loss) income from discontinued operations, net of tax									$ (72,734)	$ 1,889	$ 19,858

Discontinued Operations (Balance Sheet) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Assets
Cash and cash equivalents	$ 6,460	$ 9,937	$ 12,932
Total current assets	240,851	123,787
Total noncurrent assets of discontinued operations	0	175,104
Liabilities
Total current liabilities of discontinued operations	49,846	37,948
Total noncurrent liabilities of discontinued operations	0	23,322
Hain Pure Protein \| Held for Sale
Assets
Cash and cash equivalents	6,461	9,937
Accounts receivable, less allowance for doubtful accounts	21,616	22,671
Inventories	105,359	85,313
Prepaid expenses and other current assets	5,604	5,866
Total current assets		123,787
Property, plant and equipment, net	83,776	78,645
Goodwill	41,089	41,089
Trademarks and other intangible assets, net	51,029	52,040
Other assets	4,381	3,330
Total noncurrent assets of discontinued operations		175,104
Impairments of long-lived assets held for sale	(78,464)	0
Total assets of discontinued operations	240,851	298,891
Liabilities
Accounts payable	31,762	35,943
Accrued expenses and other current liabilities	6,880	2,005
Total current liabilities of discontinued operations		37,948
Deferred tax liabilities	11,111	23,129
Other noncurrent liabilities	93	193
Total noncurrent liabilities of discontinued operations		23,322
Total liabilities of discontinued operations	$ 49,846	$ 61,270

Acquisitions (Fiscal 2018) (Narrative) (Details) $ in Thousands			12 Months Ended
	Dec. 01, 2017 GBP (£)	Dec. 01, 2017 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)
Business Acquisition [Line Items]
Acquisition-related costs			$ 409	$ 2,035	$ 3,679
Cash paid, net of cash acquired			$ 12,368	$ 19,544	$ 157,061
Clarks
Business Acquisition [Line Items]
Cash paid, net of cash acquired	£ 9,179,000	$ 12,368
Contingent consideration, high range \| £	£ 1,500,000
Contingent consideration arrangements, period for achievement operating results	18 months	18 months
Clarks \| Sales
Business Acquisition [Line Items]
Concentration risk, percentage (for Clarks acquisition, less than)	1.00%	1.00%

Acquisitions (Fiscal 2017) (Narrative) (Details)				12 Months Ended
Acquisitions (Fiscal 2017) (Narrative) (Details)	Jun. 19, 2017 USD ($)	Apr. 28, 2017 GBP (£)	Apr. 28, 2017 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)
Business Acquisition [Line Items]
Cash paid, net of cash acquired				$ 12,368,000	$ 19,544,000	$ 157,061,000
Better Bean
Business Acquisition [Line Items]
Cash paid, net of cash acquired	$ 3,434,000
Contingent consideration, high range	$ 4,000,000
Contingent consideration arrangements, period for achievement operating results	3 years				3 years
Better Bean \| Sales
Business Acquisition [Line Items]
Concentration risk, percentage				1.00%
Yorkshire Provender
Business Acquisition [Line Items]
Cash paid, net of cash acquired		£ 12,465,000	$ 16,110,000
Contingent consideration, high range \| £		£ 1,500,000
Contingent consideration arrangements, period for achievement operating results		3 years	3 years
Yorkshire Provender \| Sales
Business Acquisition [Line Items]
Concentration risk, percentage					1.00%

Acquisitions (Fiscal 2016) (Narrative) (Details) € in Thousands, shares in Thousands, $ in Thousands						12 Months Ended
	Sep. 15, 2016 GBP (£)	Dec. 21, 2015 GBP (£)	Dec. 21, 2015 USD ($)	Jul. 24, 2015 USD ($) shares	Jul. 24, 2015 EUR (€) shares	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)
Business Acquisition [Line Items]
Cash paid, net of cash acquired						$ 12,368	$ 19,544	$ 157,061
Contingent consideration paid						$ 0	$ 3,969
FY'16 Acquisitions \| Trade Names
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired								10,965
FY'16 Acquisitions \| Customer Relationships
Business Acquisition [Line Items]
Acquired finite-lived intangible assets								$ 58,726
Acquired finite-lived intangible assets, weighted average useful life								15 years
Orchard House
Business Acquisition [Line Items]
Cash paid, net of cash acquired		£ 76,923,000	$ 114,113
Business combination, contingent consideration \| £		£ 3,000,000
Contingent consideration paid \| £	£ 1,500,000
Net sales								$ 88,580
Income before income taxes								4,622
Mona
Business Acquisition [Line Items]
Cash paid, net of cash acquired				$ 24,948	€ 22,753
Net sales								58,767
Income before income taxes								$ 3,464
Equity interest issued in business combination (shares) \| shares				240	240
Equity interest issued in business combination, value				$ 16,308
Debt assumed in business combination \| €					€ 16,252

Acquisitions (Pro Forma Results) (Details) - FY'16 Acquisitions $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2016 USD ($) $ / shares
Business Acquisition [Line Items]
Net sales from continuing operations	$ 2,481,362
Net income from continuing operations	$ 31,412
Net income per common share from continuing operations - diluted (USD per share) \| $ / shares	$ 0.30

Inventories (Details) - USD ($) $ in Thousands	3 Months Ended
Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Jun. 30, 2018	Jun. 30, 2017
Inventory, Net [Abstract]
Finished goods		$ 231,926	$ 214,547
Raw materials, work-in-progress and packaging		159,599	127,448
Total inventories		$ 391,525	$ 341,995
Inventory write-down	$ 4,913

Property, Plant and Equipment, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 555,800	$ 519,306
Less: Accumulated depreciation	245,628	227,440
Property, plant and equipment, net	310,172	291,866
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	28,378	28,092
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	83,289	83,648
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	323,348	300,750
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	54,092	50,773
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	17,894	15,613
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	31,519	29,296
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 17,280	$ 11,134

Property, Plant and Equipment, Net (Narrative) (Details) $ in Thousands	3 Months Ended			12 Months Ended
	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Jun. 30, 2018 USD ($) facility	Jun. 30, 2017 USD ($) facility	Jun. 30, 2016 USD ($)
Property, Plant and Equipment [Line Items]
Depreciation				$ 33,973	$ 33,558	$ 32,641
Number of manufacturing facilities \| facility				3	1
Impairment charge	$ 113		$ 3,449
United Kingdom
Property, Plant and Equipment [Line Items]
Impairment charge						$ 3,476
United States
Property, Plant and Equipment [Line Items]
Impairment charge					$ 2,661
Facility Closing \| United Kingdom
Property, Plant and Equipment [Line Items]
Impairment charge		$ 2,557
Expected costs of closure of facility	4,800			$ 4,800
Manufacturing Facility \| United Kingdom
Property, Plant and Equipment [Line Items]
Impairment charge				6,344	$ 23,712
Machinery and equipment \| United States
Property, Plant and Equipment [Line Items]
Impairment charge		$ 2,057		2,057
Prepaid expenses and other current assets \| Manufacturing Facility \| United Kingdom
Property, Plant and Equipment [Line Items]
Assets held-for-sale	3,767			3,767
Prepaid expenses and other current assets \| Machinery and equipment \| United States
Property, Plant and Equipment [Line Items]
Assets held-for-sale	$ 686			$ 686

Goodwill and Other Intangible Assets (Changes in Carrying Amount of Goodwill) (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Goodwill
Goodwill		$ 1,018,892,000	$ 1,018,892,000	$ 1,019,247,000
Acquisition activity			7,062,000	10,045,000
Reallocation of goodwill between reporting units			0	0
Translation and other adjustments, net			5,882,000	(10,400,000)
Impairment charge	$ (7,700,000)		(7,700,000)	0	$ (84,548,000)
Goodwill	1,024,136,000		1,024,136,000	1,018,892,000	1,019,247,000
Accumulated impairment charge	134,277,000		134,277,000	126,577,000	126,577,000
United States
Goodwill
Goodwill		588,333,000	588,333,000	605,702,000
Acquisition activity			0	0
Reallocation of goodwill between reporting units			(35,519,000)	(16,377,000)
Translation and other adjustments, net			0	(992,000)
Impairment charge			0
Goodwill	552,814,000		552,814,000	588,333,000	605,702,000
United Kingdom
Goodwill
Goodwill		329,135,000	329,135,000	332,561,000
Acquisition activity			7,062,000	6,962,000
Reallocation of goodwill between reporting units			35,519,000	0
Translation and other adjustments, net			5,447,000	(10,388,000)
Impairment charge		0	0
Goodwill	377,163,000		377,163,000	329,135,000	332,561,000
Accumulated impairment charge	97,358,000		97,358,000	97,358,000	97,358,000
Rest of World
Goodwill
Goodwill		$ 101,424,000	101,424,000	80,984,000
Acquisition activity			0	3,083,000
Reallocation of goodwill between reporting units			0	16,377,000
Translation and other adjustments, net			435,000	980,000
Impairment charge			(7,700,000)
Goodwill	94,159,000		94,159,000	101,424,000	80,984,000
Europe
Goodwill
Accumulated impairment charge	29,219,000		29,219,000	$ 29,219,000	$ 29,219,000
Cultivate \| Operating Segments
Goodwill
Accumulated impairment charge	$ 7,700,000		$ 7,700,000

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)	3 Months Ended			12 Months Ended
	Jun. 30, 2018	Sep. 30, 2017	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Segment Reporting Information [Line Items]
Goodwill impairment	$ 7,700,000			$ 7,700,000	$ 0	$ 84,548,000
Long-lived asset and intangibles impairment				$ 14,033,000	40,452,000	43,200,000
Weighted average remaining amortization period				10 years 1 month 6 days
Minimum
Segment Reporting Information [Line Items]
Finite-lived intangible asset, useful life				3 years
Maximum
Segment Reporting Information [Line Items]
Finite-lived intangible asset, useful life				25 years
Rest of World
Segment Reporting Information [Line Items]
Goodwill impairment				$ 7,700,000
United Kingdom
Segment Reporting Information [Line Items]
Goodwill impairment		$ 0		0
Long-lived asset and intangibles impairment			$ 26,373,000		26,373,000	$ 3,476,000
United States
Segment Reporting Information [Line Items]
Goodwill impairment				0
Trade Names
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment	$ 5,632,000		$ 14,079,000	5,632,000	14,079,000
Trade Names \| Rest of World
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment				5,100,000
Trade Names \| United Kingdom
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment				$ 532,000
Trade Names \| United States
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment					$ 6,500,000

Goodwill and Other Intangible Assets (Components of Other Intangible Assets) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Non-amortized intangible assets:
Trademarks and trade names	$ 385,609	$ 384,917
Amortized intangible assets:
Other intangibles	239,323	232,112
Less: accumulated amortization	(114,545)	(95,801)
Net carrying amount	510,387	521,228
Trademarks and trade names
Amortized intangible assets:
Impairment charge	$ 65,834	$ 60,202

Goodwill and Other Intangible Assets (Amortization Expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 18,202	$ 16,988	$ 17,544

Goodwill and Other Intangible Assets (Expected Amortization Expense Over Next Five Fiscal Years) (Details) $ in Thousands	Jun. 30, 2018 USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2019	$ 15,675
2020	14,379
2021	13,913
2022	13,209
2023	$ 12,620

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Payables and Accruals [Abstract]
Payroll, employee benefits and other administrative accruals	$ 75,918	$ 68,658
Facility, freight and warehousing accruals	20,970	20,019
Selling and marketing related accruals	15,546	9,734
Other accruals	3,567	8,316
Accrued expenses and other current liabilities	$ 116,001	$ 106,727

Debt and Borrowings (Components of Debt) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Line of Credit Facility [Line Items]
Less: Unamortized issuance costs	$ (692)	$ 0
Other borrowings	7,358	8,285
Long-term debt	714,106	749,761
Short-term borrowings and current portion of long-term debt	26,605	9,626
Long-term debt, less current portion	687,501	740,135
Unsecured revolving credit facility
Line of Credit Facility [Line Items]
Other borrowings	316
Credit Agreement \| Unsecured revolving credit facility
Line of Credit Facility [Line Items]
Line of credit	401,852	733,715
Term Loan \| Term Loan
Line of Credit Facility [Line Items]
Line of credit	296,250	0
Tilda \| Term Loan
Line of Credit Facility [Line Items]
Tilda short-term borrowing arrangements	$ 9,338	$ 7,761

Debt and Borrowings (Narrative) (Details)		12 Months Ended
Debt and Borrowings (Narrative) (Details)	Dec. 12, 2014 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2018 GBP (£)	Jun. 30, 2018 USD ($)	Jun. 30, 2018 EUR (€)	Mar. 31, 2018 USD ($)	Feb. 06, 2018 USD ($)
Line of Credit Facility [Line Items]
Other borrowings			$ 8,285,000			$ 7,358,000
Interest paid		$ 24,168,000	18,819,000	$ 24,208,000
Tilda \| Term Loan
Line of Credit Facility [Line Items]
Revolving credit facility \| £					£ 52,000,000
Debt term		6 months
Short-term debt, weighted average interest rate					3.92%	3.92%	3.92%
Tilda short-term borrowing arrangements			7,761,000			$ 9,338,000
Unsecured revolving credit facility
Line of Credit Facility [Line Items]
Revolving credit facility \| €							€ 12,500,000
Other borrowings						316,000
Unsecured revolving credit facility \| Tilda Hain Indian
Line of Credit Facility [Line Items]
Revolving credit facility								$ 4,000,000
Line of credit facility outstanding						$ 0
Unsecured revolving credit facility \| Eurocurrency Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate		1.10%
Short-term debt, weighted average interest rate					1.10%	1.10%	1.10%
Unsecured revolving credit facility \| Second Amended and Restated Credit Agreement
Line of Credit Facility [Line Items]
Revolving credit facility	$ 1,000,000,000
Interest coverage ratio, less than	4.0
Leverage ratio	3.5
Consolidated leverage ratio	4.0
Unsecured revolving credit facility \| Amended Credit Agreement
Line of Credit Facility [Line Items]
Debt issuance costs, revolving credit facility									$ 2,891,000
Unsecured revolving credit facility \| Credit Agreement
Line of Credit Facility [Line Items]
Line of credit facility outstanding			733,715,000			$ 401,852,000
Term Loan \| Amended Credit Agreement
Line of Credit Facility [Line Items]
Revolving credit facility									300,000,000
Additional borrowing capacity									400,000,000
Available borrowing capacity						$ 589,172,000
Weighted average interest rate					3.51%	3.51%	3.51%
Periodic payment		$ 3,750,000
Debt issuance cost									3,646,000
Amortization of debt issuance costs									$ 755,000
Term Loan \| Amended Credit Agreement \| Minimum
Line of Credit Facility [Line Items]
Commitment fee percentage	0.20%
Term Loan \| Amended Credit Agreement \| Maximum
Line of Credit Facility [Line Items]
Commitment fee percentage	0.30%
Term Loan \| Amended Credit Agreement \| Eurocurrency Rate \| Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.875%
Term Loan \| Amended Credit Agreement \| Eurocurrency Rate \| Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.70%
Term Loan \| Amended Credit Agreement \| Base Rate \| Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.00%
Term Loan \| Amended Credit Agreement \| Base Rate \| Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.70%
Term Loan \| Term Loan
Line of Credit Facility [Line Items]
Line of credit facility outstanding			$ 0			$ 296,250,000
Letter of credit \| Amended Credit Agreement
Line of Credit Facility [Line Items]
Borrowings outstanding under credit agreement						$ 8,976,000

Debt and Borrowings (Maturities of Debt Instruments) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Debt Disclosure [Abstract]
2019	$ 26,605
2020	16,988
2021	16,857
2022	15,339
2023	638,154
Thereafter	163
Long-term debt	$ 714,106	$ 749,761

Income Taxes (Components of Income Before Income Taxes) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Income Tax Disclosure [Abstract]
Domestic									$ (13,936)	$ 47,781	$ 126,686
Foreign									95,138	40,097	(39,617)
Income from continuing operations before income taxes and equity in net income of equity-method investees	$ 5,838	$ 24,032	$ 25,246	$ 26,086	$ 1,366	$ 42,150	$ 34,116	$ 10,246	$ 81,202	$ 87,878	$ 87,069

Income Taxes (Provision for Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Current:
Federal	$ (1,309)	$ 18,331	$ 9,953
State and local	1,383	(293)	1,668
Foreign	20,542	14,884	14,737
Current income tax expense	20,616	32,922	26,358
Deferred:
Federal	(22,612)	(3,198)	30,711
State and local	1,973	960	5,017
Foreign	(864)	(8,218)	(2,635)
Deferred income tax expense	(21,503)	(10,456)	33,093
Total	$ (887)	$ 22,466	$ 59,451

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Operating Loss Carryforwards [Line Items]
Cash paid for income taxes, net of refunds	$ 24,284	$ (2,900)	$ 44,225
Provisional income tax expense	25,006
Tax expense transition tax on the foreign subsidiaries’ accumulated, unremitted earnings	7,054
Tax credit carry forwards	877	877
Undistributed earnings of foreign subsidiaries	32,967
Valuation allowances	14,969	14,850	15,310
Unrecognized tax benefits	6,730	11,602	16,019	$ 10,759
Unrecognized tax benefits that would impact effective tax rate	2,917	6,409	$ 10,826
Interest and penalties, accrued	82	460
Federal
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	23,057	25,144
Foreign
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 30,065	$ 43,306

Income Taxes (Reconciliation of Expected Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Effective Income Tax Rate Reconciliation, Amount
Expected United States federal income tax at statutory rate	$ 22,818	$ 30,757	$ 30,474
State income taxes, net of federal benefit	2,774	2,757	4,263
Domestic manufacturing deduction	0	(846)	(505)
Foreign income at different rates	(7,174)	(6,539)	(4,051)
Impairment of goodwill and intangibles	1,816	0	23,172
Change in valuation allowance	119	(60)	5,067
Corporate tax reorganization	0	0	(4,173)
Unrealized foreign exchange losses	0	807	7,056
Change in reserves for uncertain tax positions	(3,859)	(4,417)	1,448
Tax Act’s transition tax	7,054	0	0
Tax Act’s impact of deferred taxes	(25,006)	0	0
Reduction of deferred tax liabilities resulting from change in United Kingdom tax rate	0	(1,841)	(4,942)
Other	571	1,848	1,642
Total	$ (887)	$ 22,466	$ 59,451
Effective Income Tax Rate Reconciliation, Percent
Expected United States federal income tax at statutory rate	28.10%	35.00%	35.00%
State income taxes, net of federal benefit	3.40%	3.10%	4.90%
Domestic manufacturing deduction	(0.00%)	(1.00%)	(0.60%)
Foreign income at different rates	(8.80%)	(7.40%)	(4.70%)
Impairment of goodwill and intangibles	2.20%	0.00%	26.60%
Change in valuation allowance	0.10%	(0.10%)	5.80%
Corporate tax reorganization	(0.00%)	(0.00%)	(4.80%)
Unrealized foreign exchange losses	0.00%	0.90%	8.10%
Change in reserves for uncertain tax positions	(4.80%)	(5.00%)	1.70%
Tax Act’s transition tax	8.70%	0.00%	0.00%
Tax Act’s impact of deferred taxes	(30.80%)	0.00%	0.00%
Reduction of deferred tax liabilities resulting from change in United Kingdom tax rate	0.00%	(2.10%)	(5.70%)
Other	0.80%	2.20%	2.00%
(Benefit) provision for income taxes	(1.10%)	25.60%	68.30%

Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Noncurrent deferred tax assets/(liabilities):
Basis difference on inventory	$ 9,139	$ 9,003
Reserves not currently deductible	11,060	23,111
Basis difference on intangible assets	(97,365)	(124,756)
Basis difference on property and equipment	(8,444)	(12,086)
Other comprehensive income	(133)	(768)
Net operating loss and tax credit carryforwards	12,414	19,049
Stock-based compensation	1,348	3,996
Other	41
Other		(616)
Valuation allowances	(14,969)	(14,850)	$ (15,310)
Total net deferred tax liabilities	$ (86,909)	(97,917)
Non-current deferred tax assets		$ 429

Income Taxes (Changes in Valuation Allowances) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Valuation Allowance [Roll Forward]
Balance at beginning of year	$ 14,850	$ 15,310
Balance at end of year	14,969	14,850
Additions charged to income tax expense
Valuation Allowance [Roll Forward]
Change in valuation allowance	1,251	1,862
Reductions credited to income tax expense
Valuation Allowance [Roll Forward]
Change in valuation allowance	(1,345)	(1,922)
Currency translation adjustments
Valuation Allowance [Roll Forward]
Change in valuation allowance	$ 213	$ (400)

Income Taxes (Unrecognized Tax Benefits Activity) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 11,602	$ 16,019	$ 10,759
Additions based on tax positions related to the current year	118	217	4,276
Additions based on tax positions related to prior years	0	0	1,404
Reductions due to lapse in statute of limitations and settlements	(4,990)	(4,634)	(420)
Balance at end of year	$ 6,730	$ 11,602	$ 16,019

Stockholders' Equity (Narrative) (Details) - shares	Jun. 30, 2018	Jun. 30, 2017
Equity [Abstract]
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares outstanding	0	0

Stockholders' Equity (Accumulated Other Comprehensive Loss) (Details) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss)	$ 11,239,000	$ (23,368,000)	$ (130,480,000)
Foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	11,497,000	(22,951,000)
Deferred gains/(losses) on cash flow hedging instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	39,000	196,000
Amounts reclassified into income	(106,000)	(575,000)
Reclassified into income, before taxes	132,000	1,233,000
Unrealized gain on available for sale investment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(191,000)	(51,000)
Amounts reclassified into income	0	13,000
Reclassified into income, before taxes	0	21,000
Intra-entity foreign currency transactions
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	$ 493,000	$ (18,385,000)

Stock-Based Compensation and Incentive Performance Plans (Stock Plans Narrative) (Details)	12 Months Ended
	Jun. 30, 2018 plan shares	Jun. 30, 2017 shares	Jun. 30, 2016 shares	Jun. 30, 2015 shares	Jun. 30, 2014 shares	Nov. 30, 2012 shares	Dec. 31, 2003 shares	May 31, 2000 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shareholder-approved plans \| plan	2
Equity instruments other than options, nonvested (in shares)	1,057,000	992,000	1,121,000	1,145,000
Number of shares available for grant (in shares)	11,678,000
Options outstanding (in shares)	122,000	122,000	342,000	1,249,000
Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)					31,500,000
Awards denominated in shares of common stock other than options and stock appreciation rights, value again available share limit	2.07
Expiration period	7 years
Options granted in the period (in shares)	0	0	0
Equity instruments other than options granted in the period (in shares)	685,000	195,000	498,000
Equity instruments other than options, nonvested (in shares)	1,057,000
Number of shares available for grant (in shares)	10,495,000
Options outstanding (in shares)	0
Long Term Incentive Plan \| Before Amendments
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)						3,200,000
Executive Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options granted in the period (in shares)	307,000	0	366,000
Executive Incentive Plan \| Subject to Achievement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options granted in the period (in shares)	307,000	0	284,000
Directors Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)							1,900,000
Expiration period	7 years
Options granted in the period (in shares)	0	0	0
Equity instruments other than options granted in the period (in shares)	0	0
Directors Stock Plan \| Before Amendments
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)								1,500,000
Prior Hain And Celestial Plans
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)	122,000

Stock-Based Compensation and Incentive Performance Plans (Compensation Cost and Related Income Tax Benefits Recognized) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Compensation cost (included in selling, general and administrative expense)	$ 11,177	$ 9,658	$ 12,688
Related income tax benefit	2,165	$ 3,622	$ 4,758
Net reduction	$ 2,222

Stock-Based Compensation and Incentive Performance Plans (Summary of Stock Option Activity) (Details) - $ / shares shares in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Outstanding
Outstanding at beginning of year (in shares)	122	342	1,249
Exercised (in shares)	0	(220)	(907)
Outstanding at end of the year (in shares)	122	122	342
Options exercisable at year end (in shares)	122	122	342
Weighted Average Exercise Price
Outstanding beginning of the year (USD per share)	$ 2.26	$ 6.66	$ 6.12
Exercised (USD per share)	0.00	9.10	5.91
Outstanding end of the year (USD per share)	2.26	2.26	6.66
Options exercisable at end of year (USD per share)	$ 2.26	$ 2.26	$ 6.66

Stock-Based Compensation and Incentive Performance Plans (Schedule of Cash Proceeds Received From Share-Based Payment Awards) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Intrinsic value of options exercised	$ 0	$ 6,507	$ 27,147
Cash received from stock option exercises	0	0	0
Tax benefit recognized from stock option exercises	$ 0	$ 2,538	$ 10,587

Stock-Based Compensation and Incentive Performance Plans (Other Narrative) (Details)				1 Months Ended	3 Months Ended		12 Months Ended
	Jun. 25, 2018 $ / shares	Sep. 26, 2017 $ / shares shares	Jul. 03, 2012 USD ($) tranche target $ / shares shares	Oct. 31, 2015 USD ($) shares	Jun. 30, 2018 USD ($) condition $ / shares shares	Sep. 30, 2017 $ / shares shares	Jun. 30, 2018 USD ($) condition $ / shares shares	Jun. 30, 2017 USD ($) $ / shares shares	Jun. 30, 2016 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value of outstanding options \| $					$ 3,358,000		$ 3,358,000
Weighted average remaining contractual life							13 years
Unrecognized compensation expense \| $					$ 0		$ 0
Shares issued in the period (in shares)							685,000	195,000	416,000
Fair value (USD per share) \| $ / shares							$ 26.13	$ 33.68	$ 24.54
CEO Grant July 2012 granted (in shares)					11,678,000		11,678,000
CEO Grant July 2012 Total Fair Value \| $							$ 17,898,000	$ 6,567,000	$ 10,203,000
Nonvested awards other than options, unrecognized cots \| $					$ 12,833,000		12,833,000
Compensation expense, other than stock-based equity or TSR grants \| $							$ 1,313,000	$ 4,044,000	$ 2,037,000
Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 granted (in shares)					10,495,000		10,495,000
Award requisite service period							3 years
Long Term Incentive Plan 2016-2018 and 2017-2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of common stock (in shares)							1
Award requisite service period							3 years
Long Term Incentive Plan 2015-2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period							3 years
Award requisite service period							2 years
Long Term Incentive Plan 2014-2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued in the period (in shares)				82,000
LTIP value settled after deducting initial equity grants \| $				$ 4,400,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation costs not yet recognized, period for recognition							1 year 9 months 18 days
CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 granted (in shares)			800,000
Number of share price targets \| target			4
Consecutive trading days			45 days
Award vesting period			5 years
CEO Grant July 2012 Total Fair Value \| $			$ 16,151,000
Compensation costs not yet recognized, period for recognition			4 years
Number of market conditions \| condition					4		4
Number of tranches \| tranche			4
CEO \| TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued in the period (in shares)		164,000			164,000	164,000
Fair value (USD per share) \| $ / shares	$ 3.19	$ 31.60			$ 3.19	$ 31.60
CEO \| Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 granted (in shares)			200,000
CEO Grant July 2012 market price targets (in USD per share) \| $ / shares			$ 31.25
CEO \| Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 market price targets (in USD per share) \| $ / shares			36.25
CEO \| Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 market price targets (in USD per share) \| $ / shares			41.25
CEO \| Tranche Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 market price targets (in USD per share) \| $ / shares			$ 50

Stock-Based Compensation and Incentive Performance Plans (Non-Vested Restricted Stock and Restricted Share Unit Awards) (Details) - $ / shares shares in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Number of Shares
Non-vested restricted stock and restricted share units - beginning of year (in shares)	992	1,121	1,145
Granted (in shares)	685	195	416
Vested (in shares)	(433)	(290)	(408)
Forfeited (in shares)	(187)	(34)	(32)
Non-vested restricted stock and restricted share units - end of year (in shares)	1,057	992	1,121
Weighted Average Grant Date Fair Value
Non-vested restricted stock and units - beginning of year, Weighted Average Grant Date Fair Value (USD per share)	$ 27.59	$ 28.24	$ 32.30
Granted (USD per share)	26.13	33.68	24.54
Vested (USD per share)	36.68	33.89	35.13
Forfeited (USD per share)	31.15	29.88	45.83
Non-vested restricted stock and units - end of year, Weighted Average Grant Date Fair Value (USD per share)	$ 22.29	$ 27.59	$ 28.24

Stock-Based Compensation and Incentive Performance Plans (Restricted Stock Grant Information) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Fair value of restricted stock and restricted share units granted	$ 17,898	$ 6,567	$ 10,203
Fair value of shares vested	15,736	9,866	18,917
Tax benefit recognized from restricted shares vesting	$ 5,235	$ 3,768	$ 7,139

Investments and Joint Ventures (Equity Method Investments) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017	Oct. 27, 2015
Hutchison Hain Organic Holdings Limited
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	50.00%
Advances to affiliate	$ 3,020	$ 1,629
Chop't
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	13.40%		14.90%
Carrying value of investment	$ 15,524	$ 16,487
Percentage of diluted basis			11.90%
HFN
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	50.00%
Carrying value of investment	$ 1,489

Investments and Joint Ventures (Available for Sale Securities) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]
Percentage of ownership (less than)	1.00%
Sale of available for sale security (in shares)	0	102,000
Loss on sale of available for sale security		$ 21
Shares held (in shares)	933,000
Available for sale securities	$ 692	882
Amortized cost basis, available for sale securities	$ 1,164	$ 1,164

Financial Instruments Measured at Fair Value (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Assets:
Cash equivalents	$ 99	$ 21,800
Forward foreign currency contracts	365	99
Available for sale securities	692	882
Assets total	1,156	22,781
Liabilities:
Forward foreign currency contracts	27	53
Contingent consideration	1,909	2,656	$ 3,553
Total	1,936	2,709
Quoted prices in active markets (Level 1)
Assets:
Cash equivalents	99	21,800
Forward foreign currency contracts	0	0
Available for sale securities	692	882
Assets total	791	22,682
Liabilities:
Forward foreign currency contracts	0	0
Contingent consideration	0	0
Total	0	0
Significant other observable inputs (Level 2)
Assets:
Cash equivalents	0	0
Forward foreign currency contracts	365	99
Available for sale securities	0	0
Assets total	365	99
Liabilities:
Forward foreign currency contracts	27	53
Contingent consideration	0	0
Total	27	53
Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	0	0
Forward foreign currency contracts	0	0
Available for sale securities	0	0
Assets total	0	0
Liabilities:
Forward foreign currency contracts	0	0
Contingent consideration	1,909	2,656
Total	$ 1,909	$ 2,656

Financial Instruments Measured at Fair Value (Narrative) (Details)						3 Months Ended		12 Months Ended
	Dec. 01, 2017 GBP (£)	Jun. 19, 2017 USD ($)	Apr. 28, 2017 GBP (£)	Sep. 15, 2016 GBP (£)	Feb. 20, 2015 CAD ($) period	Jun. 30, 2017 CAD ($)	Jun. 30, 2016 CAD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Dec. 21, 2015 GBP (£)
Business Acquisition [Line Items]
Contingent consideration paid								$ 0	$ 3,969,000
Contingent consideration adjustment								(2,281,000)	526,000
Discontinued foreign exchange hedges								0	0
Cash Flow Hedges
Business Acquisition [Line Items]
Derivative, notional amount									1,828,000
Fair value amounts of foreign exchange derivative contracts, assets									84,000
Fair Value Hedges \| Not Designated as Hedging Instrument
Business Acquisition [Line Items]
Derivative, notional amount								20,986,000	6,114,000
Fair value amounts of foreign exchange derivative contracts, assets								$ 338,000
Fair value amounts of foreign exchange derivative contracts, liabilities									$ (38,000)
Belvedere
Business Acquisition [Line Items]
Contingent consideration, high range					$ 4,000,000
Contingent consideration arrangements, number of periods for achievement operating results \| period					2
Contingent consideration arrangements, period for achievement operating results					1 year
Contingent consideration paid						$ 2,000,000	$ 2,000,000
Orchard House
Business Acquisition [Line Items]
Contingent consideration paid \| £				£ 1,500,000
Business combination, contingent consideration \| £										£ 3,000,000
Better Bean
Business Acquisition [Line Items]
Contingent consideration, high range		$ 4,000,000
Contingent consideration arrangements, period for achievement operating results		3 years							3 years
Yorkshire Provender
Business Acquisition [Line Items]
Contingent consideration, high range \| £			£ 1,500,000
Contingent consideration arrangements, period for achievement operating results			3 years
Clarks
Business Acquisition [Line Items]
Contingent consideration, high range \| £	£ 1,500,000
Contingent consideration arrangements, period for achievement operating results	18 months

Financial Instruments Measured at Fair Value (Summary of Level 3 Activity) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of year	$ 2,656	$ 3,553
Fair value of initial contingent consideration	1,547	2,652
Contingent consideration adjustment	(2,281)	526
Contingent consideration paid	0	(3,969)
Translation adjustment	(13)	(106)
Balance at end of year	$ 1,909	$ 2,656

Commitments and Contingencies (Operating Lease Future Minimum Payments) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
2019	$ 16,382
2020	14,044
2021	10,566
2022	9,453
2023	8,848
Thereafter	44,360
Total	103,653
Rent expense	$ 36,054	$ 35,153	$ 32,444

Commitments and Contingencies (Legal Proceedings) (Details)				1 Months Ended
	Apr. 26, 2017 complaint	Aug. 17, 2016 complaint	Aug. 19, 2015 USD ($) retailer distributor	Dec. 29, 2016 complaint
Securities Complaints
Loss Contingencies [Line Items]
Number of complaints		3
Derivative Complaints
Loss Contingencies [Line Items]
Number of complaints				2
Barnes Complaint
Loss Contingencies [Line Items]
Number of complaints	2
Center for Environmental Health
Loss Contingencies [Line Items]
Number of retailers \| retailer			5
Number of distributors \| distributor			1
Value per day \| $			$ 2,500

Defined Contribution Plans (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Retirement Benefits [Abstract]
Defined contribution plan eligibility minimum days worked	30 days
Defined contribution plan, costs	$ 1,371	$ 1,367	$ 1,236

Segment Information (Narrative) (Details) - segment	12 Months Ended
Segment Information (Narrative) (Details) - segment	Jun. 30, 2018	Jun. 30, 2017
Segment Reporting [Abstract]
Number of operating segments	7	8

Segment Information (Segment Data) (Details) - USD ($)	3 Months Ended								12 Months Ended
Segment Information (Segment Data) (Details) - USD ($)	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Segment Reporting Information [Line Items]
Net Sales	$ 619,598,000	$ 632,720,000	$ 616,232,000	$ 589,219,000	$ 602,891,000	$ 588,798,000	$ 587,021,000	$ 564,795,000	$ 2,457,769,000	$ 2,343,505,000	$ 2,392,864,000
Operating Income	16,580,000	29,254,000	30,965,000	29,241,000	7,174,000	49,621,000	37,859,000	14,769,000	106,040,000	109,423,000	118,801,000
Acquisition and restructuring charges										10,388,000	12,065,000
Accounting review and remediation costs, net of insurance proceeds	2,887,000	$ 3,313,000	$ 4,451,000	3,642,000	9,473,000	$ 7,124,000	$ 7,005,000	$ 5,960,000	9,293,000	29,562,000	0
Long-lived asset and intangibles impairment									14,033,000	40,452,000	43,200,000
Goodwill impairment	7,700,000								7,700,000	0	84,548,000
Trade Names
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment	$ 5,632,000				14,079,000				5,632,000	14,079,000
Rest of World
Segment Reporting Information [Line Items]
Goodwill impairment									7,700,000
Rest of World \| Trade Names
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment									5,100,000
United States
Segment Reporting Information [Line Items]
Goodwill impairment									0
United States \| Trade Names
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment										6,500,000
United Kingdom
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment					$ 26,373,000					$ 26,373,000	$ 3,476,000
Goodwill impairment				$ 0					0
United Kingdom \| Trade Names
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment									$ 532,000
Sales \| Customer Concentration Risk \| First Customer
Segment Reporting Information [Line Items]
Concentration risk, percentage									11.00%	12.00%	12.00%
Sales \| Customer Concentration Risk \| Second Customer
Segment Reporting Information [Line Items]
Concentration risk, percentage									11.00%	11.00%	12.00%
Operating Segments
Segment Reporting Information [Line Items]
Net Sales									$ 2,457,769,000	$ 2,343,505,000	$ 2,392,864,000
Operating Income									181,025,000	229,265,000	287,378,000
Operating Segments \| Rest of World
Segment Reporting Information [Line Items]
Net Sales									434,869,000	383,942,000	368,864,000
Operating Income									38,660,000	32,010,000	27,898,000
Operating Segments \| United States
Segment Reporting Information [Line Items]
Net Sales									1,084,871,000	1,107,806,000	1,164,817,000
Operating Income									86,319,000	145,307,000	188,671,000
Operating Segments \| United Kingdom
Segment Reporting Information [Line Items]
Net Sales									938,029,000	851,757,000	859,183,000
Operating Income									56,046,000	51,948,000	70,809,000
Corporate and Other
Segment Reporting Information [Line Items]
Operating Income									(74,985,000)	(119,842,000)	(168,577,000)
Acquisition and restructuring charges									12,841,000
Accounting review and remediation costs, net of insurance proceeds									$ 9,293,000	29,562,000
Long-lived asset and intangibles impairment										14,079,000	39,724,000
Corporate and Other \| United States
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment											18,792,000
Corporate and Other \| United Kingdom
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment										$ 7,579,000	20,932,000
Goodwill impairment											$ 84,548,000

Segment Information (Net Sales) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Revenue from External Customer [Line Items]
Net Sales	$ 619,598	$ 632,720	$ 616,232	$ 589,219	$ 602,891	$ 588,798	$ 587,021	$ 564,795	$ 2,457,769	$ 2,343,505	$ 2,392,864
United States
Revenue from External Customer [Line Items]
Net Sales									1,144,832	1,167,688	1,237,240
United Kingdom
Revenue from External Customer [Line Items]
Net Sales									938,029	851,757	859,183
All Other
Revenue from External Customer [Line Items]
Net Sales									374,908	324,060	296,441
Grocery
Revenue from External Customer [Line Items]
Net Sales									1,842,535	1,743,860	1,800,640
Snacks
Revenue from External Customer [Line Items]
Net Sales									302,795	312,784	307,797
Personal Care
Revenue from External Customer [Line Items]
Net Sales									196,245	176,408	171,669
Tea
Revenue from External Customer [Line Items]
Net Sales									$ 116,194	$ 110,453	$ 112,758

Segment Information (Long-lived Assets) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Segment Reporting Information [Line Items]
Long lived assets	$ 360,564	$ 341,099
United States
Segment Reporting Information [Line Items]
Long lived assets	99,650	112,373
United Kingdom
Segment Reporting Information [Line Items]
Long lived assets	174,214	165,334
All Other
Segment Reporting Information [Line Items]
Long lived assets	$ 86,700	$ 63,392

Quarterly Financial Data (Unaudited) (Schedule of Quarterly Data) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Quarterly Financial Information Disclosure [Abstract]
Net sales	$ 619,598	$ 632,720	$ 616,232	$ 589,219	$ 602,891	$ 588,798	$ 587,021	$ 564,795	$ 2,457,769	$ 2,343,505	$ 2,392,864
Gross profit	125,097	133,013	133,950	123,388	143,862	139,203	130,011	106,320	515,448	519,396	565,462
Operating income (loss)	16,580	29,254	30,965	29,241	7,174	49,621	37,859	14,769	106,040	109,423	118,801
Income before income taxes and equity in earnings of equity-method investees	5,838	24,032	25,246	26,086	1,366	42,150	34,116	10,246	81,202	87,878	87,069
Net income from continuing operations	(4,556)	25,241	43,130	18,613	(1,504)	32,824	24,769	9,452	82,428	65,541	27,571
Net (loss) income from discontinued operations, net of tax	(65,385)	(12,555)	3,973	1,233	1,817	(1,496)	2,417	(849)	(72,734)	1,889	19,858
Net income	$ (69,941)	$ 12,686	$ 47,103	$ 19,846	$ 313	$ 31,328	$ 27,185	$ 8,604	$ 9,694	$ 67,430	$ 47,429
Net income (loss) per common share:
Basic net income per common share from continuing operations (USD per share)	$ (0.04)	$ 0.24	$ 0.42	$ 0.18	$ (0.01)	$ 0.32	$ 0.24	$ 0.09	$ 0.79	$ 0.63	$ 0.27
Basic net (loss) income per common share from discontinued operations (USD per share)	(0.63)	(0.12)	0.04	0.01	0.02	(0.01)	0.02	(0.01)	(0.70)	0.02	0.19
Basic net income per common share (USD per share)	(0.67)	0.12	0.45	0.19	0.00	0.30	0.26	0.08	0.09	0.65	0.46
Diluted net (loss) income per common share from continuing operations (USD per share)	(0.04)	0.24	0.41	0.18	(0.01)	0.31	0.24	0.09	0.79	0.63	0.26
Diluted net (loss) income per common share from discontinued operations (USD per share)	(0.63)	(0.12)	0.04	0.01	0.02	(0.01)	0.02	(0.01)	(0.70)	0.02	0.19
Diluted net income per common share (USD per share)	$ (0.67)	$ 0.12	$ 0.45	$ 0.19	$ 0.00	$ 0.30	$ 0.26	$ 0.08	$ 0.09	$ 0.65	$ 0.46

Quarterly Financial Data (Unaudited) (Narrative) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Effect of Fourth Quarter Events [Line Items]
Goodwill impairment	$ 7,700,000								$ 7,700,000	$ 0	$ 84,548,000
Goodwill impairment, net	5,553,000
Intangibles impairment									14,033,000	40,452,000	43,200,000
Impairment charge related to long-lived assets	113,000		$ 3,449,000
Impairment charge related to long-lived assets, net	104,000		2,593,000
Accounting review costs	2,887,000	$ 3,313,000	4,451,000	$ 3,642,000	$ 9,473,000	$ 7,124,000	$ 7,005,000	$ 5,960,000	9,293,000	29,562,000	0
Accounting review costs, net	1,941,000	2,654,000	$ 3,346,000	2,638,000	6,773,000	$ 5,029,000	$ 5,050,000	$ 4,112,000
Insurance proceeds				5,000,000
Insurance proceeds, net				3,622,000
United Kingdom
Effect of Fourth Quarter Events [Line Items]
Impairment charge related to long-lived assets											3,476,000
United States
Effect of Fourth Quarter Events [Line Items]
Impairment charge related to long-lived assets										2,661,000
Facility Closing \| United Kingdom
Effect of Fourth Quarter Events [Line Items]
Impairment charge related to long-lived assets		2,557,000
Machinery and equipment \| United Kingdom
Effect of Fourth Quarter Events [Line Items]
Impairment charge related to long-lived assets, net		2,050,000
Machinery and equipment \| United States
Effect of Fourth Quarter Events [Line Items]
Impairment charge related to long-lived assets		2,057,000							2,057,000
Impairment charge related to long-lived assets, net		$ 1,648,000
Rest of World
Effect of Fourth Quarter Events [Line Items]
Goodwill impairment									7,700,000
United Kingdom
Effect of Fourth Quarter Events [Line Items]
Goodwill impairment				$ 0					0
Intangibles impairment					26,373,000					26,373,000	$ 3,476,000
Intangibles impairment, net					20,877,000
Held for Sale \| Hain Pure Protein
Effect of Fourth Quarter Events [Line Items]
Impairments of long-lived assets held for sale	78,464,000				0				78,464,000	0
Trade Names
Effect of Fourth Quarter Events [Line Items]
Intangibles impairment	5,632,000				14,079,000				5,632,000	$ 14,079,000
Intangibles impairment, net					$ 10,733,000
Trade Names \| Rest of World
Effect of Fourth Quarter Events [Line Items]
Intangibles impairment									5,100,000
Intangibles impairment, net	$ 5,192,000
Trade Names \| United Kingdom
Effect of Fourth Quarter Events [Line Items]
Intangibles impairment									$ 532,000

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Allowance for doubtful accounts
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 1,447	$ 936	$ 896
Charged to costs and expenses	1,880	1,077	208
Charged to other accounts	49	149	54
Deductions	(1,290)	(715)	(222)
Balance at end of period	2,086	1,447	936
Valuation allowance for deferred tax assets
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	14,850	15,310	10,926
Charged to costs and expenses	1,251	1,862	7,484
Charged to other accounts	0	0	0
Deductions	(1,132)	(2,322)	(3,100)
Balance at end of period	$ 14,969	$ 14,850	$ 15,310